Acne

L12_ACNE

acne: An inflammatory process of the sebaceous glands which is characterized by comedones, nodules, papules and/or pustules on the skin.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L70 Cause of death: ICD-10 — L70 2 out of 7 registries used, show all original rules.	5602
4. Check minimum number of events None	5602
5. Include endpoints L12_ACNE_VULGARIS L12_ACNE_CONGLOBLATA L12_ACNE_VARIOLIFORMIS L12_ACNE_TROPICA L12_ACNE_INFANT L12_ACNE_EXCOR L12_ACNE_NAS	5941
6. Filter based on genotype QC (FinnGen only)	5306

Control definitions (FinnGen only)

Control exclude: L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L60-L75
Name in latin: Acne

NAME	L12_ACNE
CONTROL_EXCLUDE	L12_DISORDSKINAPPENDIX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	L12_ACNE_VULGARIS\|L12_ACNE_CONGLOBLATA\|L12_ACNE_VARIOLIFORMIS\|L12_ACNE_TROPICA\|L12_ACNE_INFANT\|L12_ACNE_EXCOR\|L12_ACNE_NAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L70
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L70
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Acne based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	52364	25973	26178
Only index persons	51216	25574	25642
Unadjusted period prevalence (%)
Whole population	0.74	0.74	0.73
Only index persons	0.96	0.94	0.98
Median age at first event (years)
Whole population	20.29	21.46	19.05
Only index persons	20.23	21.46	19.00

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5306	3567	1739
Unadjusted period prevalence (%)	1.11	1.27	0.80
Median age at first event (years)	25.08	27.25	20.62

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5567: Matched controls
55360

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L73.2

ICD-10 Finland

Hidradenitis suppurativa

23.9

307.7

259

113

L70.9

ICD-10 Finland

Acne, unspecified

18.8

307.7

573

335

G03HB01

ATC

cyproterone and estrogen; oral

4.2

307.7

1460

4293

L70.0

ICD-10 Finland

Acne vulgaris

93.3

307.7

4172

1720

D10BA01

ATC

isotretinoin; oral

19.7

307.7

3204

3559

L70.8

ICD-10 Finland

Other acne

35.6

307.7

308

E0000UV, ,

ATC

3.1

307.7

3322

17873

L70.1

ICD-10 Finland

Acne conglobata

58.6

307.7

333

J01AA04

ATC

lymecycline; systemic

8.0

307.7

2561

5347

L70

ICD-10 Finland

Acne

12.9

307.7

1487

1520

D10AX03

ATC

azelaic acid; topical

6.3

307.7

1807

3922

J01AA07

ATC

tetracycline; systemic

7.1

307.7

2362

5194

S96

ICPC

Acne

5.9

307.7

639

1200

D10AF01

ATC

clindamycin; topical

5.2

257.8

568

1180

E0001A1, ,

ATC

5.6

216.2

436

834

70610

ICD-8 Finland

Diseases of sebaceous glands, Acne vulgaris

+∞

210.3

201

E000001, ,

ATC

2.5

182.7

1623

7952

L73.8

ICD-10 Finland

Other specified follicular disorders

12.8

164.3

161

129

L71.9

ICD-10 Finland

Rosacea, unspecified

7.7

162.3

232

311

L71.8

ICD-10 Finland

Other rosacea

12.1

148.6

150

126

C03DA01

ATC

spironolactone; oral

3.8

140.1

463

1301

D06BX01

ATC

metronidazole; topical

3.1

135.3

630

2196

XQ848

NOMESCO Finland

Dermatological photography

6.0

127.7

232

400

L70.2

ICD-10 Finland

Acne varioliformis

15.3

117.2

103

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.0

112.4

1631

9432

L72.1

ICD-10 Finland

Trichilemmal cyst

3.3

83.8

338

1074

7061A

ICD-9 Finland

Diseases of sebaceous glands, Other acne[ACNE VULGARIS]

+∞

83.4

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.9

72.5

363

1305

D10AD01

ATC

tretinoin; topical

4.3

64.4

171

408

L71

ICD-10 Finland

Rosacea

4.0

63.0

184

471

L71.0

ICD-10 Finland

Perioral dermatitis

3.6

59.5

203

579

TQW80

NOMESCO Finland

Local dermatologic skincare

4.2

58.9

158

380

L73.9

ICD-10 Finland

Follicular disorder, unspecified

9.0

57.7

J01FF01

ATC

clindamycin; systemic

1.7

54.8

1186

7515

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

53.8

1242

8002

S10

ICPC

Boil/carbuncle

2.4

51.5

366

1562

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.8

49.0

777

4480

L68.0

ICD-10 Finland

Hirsutism

7.6

48.0

N06AX11

ATC

mirtazapine; oral

1.6

48.0

1636

11561

J02AC01

ATC

fluconazole; systemic

1.5

47.9

1909

13970

D07AC01

ATC

betamethasone; topical

1.6

47.1

1616

11426

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

45.1

1478

10323

H02AB06

ATC

prednisolone; systemic

1.5

45.0

1971

14672

J04BA02

ATC

dapsone; oral

10.2

44.6

L70.5

ICD-10 Finland

Acné excoriée

58.0

44.3

Z94.0

ICD-10 Finland

Kidney transplant status

5.2

43.8

174

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

42.2

959

6108

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.5

41.8

276

1137

J01DB01

ATC

cefalexin; oral

1.6

41.4

4488

39920

N05BA04

ATC

oxazepam; oral

1.6

41.2

1240

8462

L04AA06

ATC

mycophenolic acid; systemic

3.8

41.2

128

343

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.7

41.1

207

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

39.1

1586

11542

380

Kela drug reimbursment

Adalimumab (hidradenitis suppurativa)

+∞

38.5

A02BC02

ATC

pantoprazole; systemic

1.4

38.3

2678

21645

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.4

38.2

224

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.4

38.1

269

1143

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.9

37.1

115

N03AX16

ATC

[U] pregabalin

1.7

37.0

719

4377

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

4.8

37.0

177

N05AH04

ATC

quetiapine; oral

1.6

36.4

1157

7963

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

3.5

36.3

129

378

TK800

NOMESCO Finland

Hemodialysis

4.2

36.0

226

S29

ICPC

Skin symptom/complaint other

1.6

35.9

1045

7049

N05CF01

ATC

zopiclone; oral

1.6

35.8

998

6660

D07XC01

ATC

betamethasone; topical

2.0

35.6

441

2337

127

Kela drug reimbursment

Transplant complication

3.8

35.4

107

281

N06AX16

ATC

venlafaxine; oral

1.6

35.3

860

5552

UJF32

NOMESCO Finland

Coloscopy

1.7

35.1

749

4672

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.2

34.8

137

Kela drug reimbursment

Uraemia requiring dialysis

6.0

34.7

102

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

34.6

794

5047

L04AX01

ATC

azathioprine; systemic

2.4

34.3

254

1103

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

33.6

1038

7083

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.5

33.4

218

894

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

5.8

33.3

106

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

33.2

864

5664

J01AA02

ATC

doxycycline; systemic

1.4

32.6

3078

25925

D05BB02

ATC

acitretin; oral

4.2

32.6

209

L21.0

ICD-10 Finland

Seborrhoea capitis

4.4

32.1

182

N02AX02

ATC

tramadol; systemic, rectal

1.5

31.0

1427

10557

TQW99

NOMESCO Finland

Other minor procedure on skin

2.8

31.0

153

545

D07AD01

ATC

clobetasol; topical

1.7

30.6

596

3620

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

30.4

547

3252

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

30.2

914

6195

70612

ICD-8 Finland

Diseases of sebaceous glands, Acne alia sive NUD

+∞

30.2

N05CD07

ATC

temazepam; oral

2.5

30.2

200

826

D07AB08

ATC

desonide; topical

1.7

29.6

588

3590

L04AA01

ATC

[U] ciclosporin

4.7

29.6

145

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

29.5

969

6684

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

5.8

29.5

N06AB04

ATC

citalopram; systemic

1.6

29.4

784

5159

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.2

29.3

254

1178

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

28.8

771

5074

L04AD01

ATC

ciclosporin; systemic

3.3

28.7

111

344

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

28.4

1538

11696

J01MA02

ATC

ciprofloxacin; systemic

1.5

27.6

1269

9354

R06AE07

ATC

cetirizine; oral

1.4

27.4

2437

20095

N03AX09

ATC

lamotrigine; oral

1.9

27.2

385

2127

N06AX21

ATC

duloxetine; oral

1.7

27.2

541

3302

J01FA01

ATC

erythromycin; systemic

1.5

27.2

874

5991

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

27.0

482

2856

XQ800

NOMESCO Finland

Prick test

1.7

26.8

506

3043

B03XA02

ATC

darbepoetin alfa; parenteral

4.3

26.6

158

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

26.2

701

4607

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

25.9

527

3235

196

Kela drug reimbursment

Paricalcitol and cinacalcet

8.0

25.8

V03AE02

ATC

sevelamer; oral

7.7

25.7

A12AA04

ATC

calcium carbonate; oral

4.3

25.2

148

XQ802

NOMESCO Finland

Epicutan test

2.1

25.1

232

1103

D07AC13

ATC

mometasone; topical

1.4

24.8

1159

8547

S97

ICPC

Chronic ulcer skin

2.6

24.7

149

589

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

24.6

242

1179

B05DA

ATC

Isotonic solutions

5.4

24.5

Z49.2

ICD-10 Finland

Other dialysis

5.6

24.5

V03AE01

ATC

polystyrene sulfonate; oral

5.5

24.2

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

4.4

24.0

133

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.6

24.0

121

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

23.9

798

5500

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.3

23.7

266

N18.8

ICD-10 Finland

Other chronic renal failure

4.1

23.6

160

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

5.6

23.6

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.9

23.6

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

23.5

1091

8023

C07AA05

ATC

propranolol; systemic

1.4

23.2

1090

8032

N06AX12

ATC

bupropion; oral

1.6

23.2

598

3890

N03AX12

ATC

[U] gabapentin; oral

1.7

23.2

498

3097

B03XA01

ATC

erythropoietin; parenteral

7.2

23.1

S21

ICPC

Skin texture symptom/complaint

1.5

22.9

713

4839

M79.6

ICD-10 Finland

Pain in limb

1.3

22.8

1991

16230

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.0

22.8

258

1324

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

22.8

2021

16516

B05DB

ATC

Hypertonic solutions

5.4

22.7

B07.9

ICD-10 Finland

Verruca simplex

2.0

22.6

263

1362

C03CA01

ATC

furosemide; systemic

1.8

22.6

388

2271

L20.0

ICD-10 Finland

Besnier prurigo

1.5

22.5

699

4740

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

22.3

326

1818

L04AD02

ATC

tacrolimus; systemic

3.5

22.2

218

R53

ICD-10 Finland

Malaise and fatigue

1.4

22.2

1336

10265

N76.0

ICD-10 Finland

Acute vaginitis

1.6

22.2

640

4270

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.7

22.1

116

428

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.1

22.0

151

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.1

22.0

201

952

Z71.8

ICD-10 Finland

Other specified counselling

1.3

22.0

2038

16733

N06AX22

ATC

agomelatine; oral

2.2

22.0

191

887

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.2

21.9

186

856

R06.0

ICD-10 Finland

Dyspnoea

1.4

21.9

937

6781

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

21.8

2592

22044

S04

ICPC

Lump/swelling localized

1.5

21.7

661

4465

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.3

21.5

128

E000008, ,

ATC

5.6

21.4

L91.0

ICD-10 Finland

Hypertrophic scar

2.7

21.4

114

424

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

21.4

2027

16680

N02BE01

ATC

paracetamol; systemic, rectal

1.4

21.3

4333

39720

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.2

21.3

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

21.2

2039

16807

N06AB10

ATC

escitalopram; oral

1.4

21.1

1357

10525

A02BC03

ATC

lansoprazole; oral

1.5

21.1

726

5027

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.8

21.1

165

P01AB01

ATC

metronidazole; oral, rectal

1.3

21.1

1661

13298

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

21.0

2436

20603

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

20.9

206

1005

H3603, E103,

ICD-10 Finland

3.5

20.9

203

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.9

20.7

342

A02BC05

ATC

esomeprazole; systemic

1.4

20.7

1367

10646

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

20.6

1751

14165

L04AB04

ATC

adalimumab; parenteral

2.3

20.6

151

654

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

20.4

1213

9284

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

3.2

20.4

256

M25.5

ICD-10 Finland

Pain in joint

1.3

20.3

1519

12050

J04AB02

ATC

rifampicin; systemic

4.5

20.3

109

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.7

20.3

174

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

20.3

472

2992

N06AB03

ATC

fluoxetine; oral

1.6

20.1

578

3850

J01MA12

ATC

levofloxacin; systemic

1.6

20.1

478

3048

WZC00, ,

SPAT

1.4

20.1

933

6844

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.8

20.0

287

1592

R4110

NOMESCO Finland

Physiotherapy

1.4

19.9

983

7287

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

19.7

1608

12910

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.9

19.7

274

1505

N06AB06

ATC

sertraline; oral

1.5

19.7

755

5339

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

19.6

675

4672

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

2.7

19.5

104

387

A11CC03

ATC

alfacalcidol; systemic

3.0

19.5

294

N05BE01

ATC

buspirone; oral

2.4

19.5

140

601

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.1

19.4

197

972

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

19.3

323

1875

L72.0

ICD-10 Finland

Epidermal cyst

3.8

19.3

157

L04AX03

ATC

methotrexate; systemic

1.7

19.3

376

2278

C07AB07

ATC

bisoprolol; oral

1.4

19.1

1025

7700

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

19.1

367

2216

A06AD11

ATC

lactulose; oral

1.7

19.1

342

2026

N06AX26

ATC

vortioxetine; oral

1.5

19.0

572

3847

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

5.9

19.0

N06AB05

ATC

paroxetine; oral

1.9

18.9

260

1423

N05CF02

ATC

zolpidem; oral

1.5

18.8

624

4284

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

18.8

275

1536

R06AX27

ATC

desloratadine; oral

1.3

18.7

1797

14742

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

18.7

129

544

L05.9

ICD-10 Finland

Pilonidal cyst without abscess

2.6

18.7

105

402

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

18.6

505

3318

J01DA01

ATC

[U] cefalexin

1.3

18.3

2686

23270

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

18.3

186

918

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

18.2

409

2570

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.4

18.1

977

7340

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

7.1

18.1

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.2

17.9

152

700

N05AX12

ATC

aripiprazole; systemic

1.7

17.9

363

2221

R03AC02

ATC

salbutamol; inhalant

1.3

17.9

2777

24206

Z3231

NOMESCO Finland

Registered nurse

1.4

17.7

1128

8701

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

17.7

196

998

E000002, ,

ATC

1.5

17.7

675

4763

D02AX

ATC

Other emollients and protectives

2.0

17.6

200

1029

R50.9

ICD-10 Finland

Fever, unspecified

1.4

17.6

774

5612

SPAT1301

SPAT

No procedures

1.3

17.5

1491

12006

A10AB04

ATC

insulin lispro; parenteral

2.1

17.5

168

813

ZX120

NOMESCO Finland

Intravenous

1.7

17.5

304

1786

N05BA01

ATC

diazepam; systemic, rectal

1.6

17.4

432

2780

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

17.4

4407

40867

L01BA01

ATC

methotrexate; systemic

2.3

17.4

127

550

K65.0

ICD-10 Finland

Acute peritonitis

4.5

17.3

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

17.3

1070

8213

M79.1

ICD-10 Finland

Myalgia

1.4

17.3

793

5789

D02AE01

ATC

carbamide; topical

1.8

17.3

280

1611

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

17.3

4286

39593

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.7

17.3

326

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.7

17.2

346

2112

S18

ICPC

Laceration/cut

1.3

16.9

1805

14971

N02BF02

ATC

pregabalin; oral

1.8

16.9

271

1555

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

16.9

364

2264

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

16.8

373

2336

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.4

16.8

737

5336

D06AX01

ATC

fusidic acid; topical

1.5

16.8

484

3222

N18.0

ICD-10 Finland

End-stage renal disease

4.9

16.7

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.3

16.7

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

5.6

16.6

A02BC01

ATC

omeprazole; systemic

1.4

16.5

949

7193

A10AB01

ATC

insulin (human); parenteral

2.0

16.5

187

961

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

16.5

243

1360

N05AH03

ATC

olanzapine; systemic

1.6

16.4

386

2451

V03AE03

ATC

lanthanum carbonate; oral

6.7

16.4

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

2.4

16.4

117

501

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.5

16.4

489

3279

NHQ40

NOMESCO Finland

Amputation of toe

5.2

16.4

SPAT1260

SPAT

Consultation of another employee

1.4

16.3

792

5835

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

16.2

131

593

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

16.1

751

5496

A10AB05

ATC

insulin aspart; parenteral

1.7

16.0

294

1753

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

16.0

771

5673

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.1

16.0

148

707

A63.0

ICD-10 Finland

Anogenital (venereal) warts

1.7

15.9

331

2039

L30.3

ICD-10 Finland

Infective dermatitis

2.1

15.9

156

761

G44.2

ICD-10 Finland

Tension-type headache

1.4

15.7

726

5301

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

6.3

15.7

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

15.6

469

3150

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.9

15.5

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

4.0

15.5

107

N05AX08

ATC

risperidone; systemic

1.6

15.5

330

2046

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

6.0

15.4

QAA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of head or neck

5.6

15.4

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.9

15.4

210

1148

Z3226

NOMESCO Finland

Physiotherapist

1.4

15.4

653

4698

N02BF01

ATC

gabapentin; oral

1.6

15.3

341

2138

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.6

15.2

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

15.1

686

4993

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

15.1

1540

12659

H02AB04

ATC

methylprednisolone; systemic

1.6

15.1

415

2734

L60.0

ICD-10 Finland

Ingrowing nail

1.8

15.0

244

1406

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.6

15.0

137

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

14.9

439

2934

H05BX01

ATC

cinacalcet; oral

6.2

14.9

WZC30

NOMESCO Finland

Teaching

1.5

14.9

506

3488

QBA10

NOMESCO Finland

Incision of skin of trunk

3.3

14.9

167

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

14.7

370

2388

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

14.7

596

4248

ZXC50

NOMESCO Finland

Cryotherapy

3.3

14.7

168

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

14.6

1896

16043

M54.5

ICD-10 Finland

Low back pain

1.3

14.5

1718

14371

J01FA10

ATC

azithromycin; systemic

1.3

14.5

3420

30964

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

14.4

805

6064

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

2.9

14.4

222

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

14.4

264

1574

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.6

14.4

323

P29

ICPC

Psychological sympt/compl other

1.4

14.3

722

5348

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

14.2

306

1904

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

14.2

806

6090

L65.9

ICD-10 Finland

Nonscarring hair loss, unspecified

4.3

14.1

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.3

14.1

K07.60

ICD-10 Finland

Snapping jaw

1.6

14.1

341

2181

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

14.1

181

971

XQ845

NOMESCO Finland

Dermatoscopy

3.2

14.0

173

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

14.0

3643

33282

E000007, ,

ATC

1.6

13.9

304

1896

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

13.9

883

6782

WX002

NOMESCO Finland

Sedation and analgesia

1.5

13.9

522

3665

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

13.9

386

2547

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

13.8

4084

37835

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.4

13.7

630

4590

SFA10

NOMESCO Finland

One-surface restoration

1.2

13.7

3220

29043

A46

ICD-10 Finland

Erysipelas

1.6

13.7

341

2196

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

13.7

291

1805

M03BX02

ATC

tizanidine; oral

1.2

13.6

2575

22675

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

13.6

3586

32746

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

13.6

236

1387

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

13.6

1728

14556

A10AE05

ATC

insulin detemir; parenteral

1.8

13.5

214

1224

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.8

13.5

241

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

13.5

1473

12180

SPAT1240

SPAT

Therapeutic discussion

1.4

13.5

838

6417

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

13.5

181

986

A07EC02

ATC

mesalazine; oral, rectal

1.7

13.4

247

1474

N06AX03

ATC

mianserin; oral

2.1

13.4

128

619

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

13.4

249

1490

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

5.8

13.4

A10AA02, ,

ATC

2.1

13.3

121

574

R42

ICD-10 Finland

Dizziness and giddiness

1.4

13.3

752

5670

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

13.3

761

5749

T89

ICPC

Diabetes insulin dependent

1.7

13.2

226

1322

N30.0

ICD-10 Finland

Acute cystitis

1.3

13.1

849

6538

R21

ICPC

Throat symptom/complaint

1.2

13.1

1925

16470

KBV00

NOMESCO Finland

Insertion of stent into ureter

4.1

13.1

UKC02

NOMESCO Finland

Cystoscopy

1.6

13.0

302

1912

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.6

13.0

275

R11

ICD-10 Finland

Nausea and vomiting

1.5

13.0

488

3429

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

12.9

940

7364

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

12.9

190

1066

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.7

12.8

263

1615

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.9

12.8

162

865

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.6

12.8

271

N06AA09

ATC

amitriptyline; systemic

1.8

12.8

183

1016

SPAT1263

SPAT

Sampling

1.2

12.8

2183

18971

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.4

12.7

367

EMB10

NOMESCO Finland

Tonsillectomy

1.4

12.7

504

3579

OAA12, ,

SPAT

0.6

12.6

288

4388

A02BA02

ATC

ranitidine; systemic

1.5

12.6

366

2439

M03AX01

ATC

botulinum toxin; parenteral

2.1

12.6

110

515

N06AB08

ATC

fluvoxamine; oral

2.5

12.6

309

K03.00

ICD-10 Finland

Approximal wear

1.5

12.5

402

2736

M01AE02

ATC

naproxen; oral, rectal

1.2

12.5

3034

27325

H00.00

ICD-10 Finland

Hordeolum

1.6

12.5

266

1650

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.9

12.5

151

795

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

12.5

224

1329

WQ031, ,

NOMESCO Finland

+∞

12.5

L21

ICD-10 Finland

Seborrhoeic dermatitis

2.2

12.5

102

465

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

12.4

2184

19017

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

12.4

962

7595

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

3.0

12.4

171

A07AA02

ATC

nystatin; oral

2.0

12.4

140

721

L63.8

ICD-10 Finland

Other alopecia areata

13.1

12.4

G43.3

ICD-10 Finland

Complicated migraine

2.0

12.3

135

687

N05AA02

ATC

levomepromazine; systemic

1.9

12.3

143

743

A10AA01, ,

ATC

2.1

12.3

117

566

N06AG02

ATC

moclobemide; oral

2.1

12.2

116

561

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

12.2

755

5771

SDA03

NOMESCO Finland

Periodontal treatment

1.2

12.2

2133

18558

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

12.1

1364

11295

CKC15

NOMESCO Finland

Panretinal photocoagulation

4.2

12.1

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.6

12.0

255

1580

A10AE04

ATC

insulin glargine; parenteral

1.6

12.0

281

1783

N03AG01

ATC

valproic acid; systemic, rectal

1.6

12.0

260

1621

H13

ICPC

Plugged feeling ear

1.4

12.0

606

4487

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.4

12.0

494

3531

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.6

12.0

275

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

11.9

529

3830

W78

ICPC

Pregnancy

0.8

11.9

1133

13641

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

11.8

244

1503

H02AB09

ATC

hydrocortisone; systemic

2.0

11.8

123

616

J01FA06

ATC

roxithromycin; oral

1.3

11.8

1305

10782

QXA70, ,

SPAT

1.7

11.8

203

1192

JLE03

NOMESCO Finland

Allogenic total transplantation of pancreas with pancreaticoenterostomy

11.6

11.8

R51.80

ICD-10 Finland

Headache

1.3

11.8

960

7631

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

5.3

11.7

N05AF03

ATC

chlorprothixene; systemic

2.1

11.7

114

557

N05AN01

ATC

lithium; oral

1.9

11.7

133

687

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

11.7

360

2432

X23

ICPC

Fear sexually transm dis female

1.4

11.6

687

5213

R52.9

ICD-10 Finland

Pain, unspecified

1.5

11.6

436

3062

OAA11, ,

SPAT

0.7

11.5

457

6248

P01

ICPC

Feeling anxious/nervous/tense

1.3

11.5

1412

11801

WW200

NOMESCO Finland

Immunization

2.0

11.5

123

622

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

11.5

457

3245

K50.8

ICD-10 Finland

Other Crohn disease

2.2

11.5

423

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

11.5

1488

12513

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

11.5

956

7618

L01

ICPC

Neck symptom/complaint

1.3

11.5

834

6524

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

0.7

11.4

392

5503

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

11.3

308

2024

H02AB07

ATC

prednisone; oral

1.5

11.3

348

2348

R01AD58

ATC

fluticasone, combinations; nasal

1.2

11.3

1485

12499

N05BA12

ATC

alprazolam; oral

1.6

11.3

293

1905

AA1AD

NOMESCO Finland

CT of head and brain

1.3

11.3

681

5184

Z01.2

ICD-10 Finland

Dental examination

1.2

11.2

2846

25625

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

11.2

2414

21389

N06AA12

ATC

doxepin; systemic

2.1

11.2

102

486

K51.5

ICD-10 Finland

Left sided colitis

1.9

11.2

148

804

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

2.7

11.1

204

SPAT1153

SPAT

Removal of sutures

1.3

11.1

913

7259

H01.0

ICD-10 Finland

Blepharitis

1.5

11.1

381

2631

SPAT1310

SPAT

Counselling related to known health issue

1.2

11.1

1646

14039

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.8

11.1

1258

14858

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

11.0

288

1877

MA3AE

NOMESCO Finland

Combined first trimester screening

0.7

11.0

380

5329

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

11.0

427

3017

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

11.0

790

6166

TLC02

NOMESCO Finland

Simple extraction of IUD

1.7

11.0

212

1284

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.6

11.0

237

1477

A29

ICPC

General symptom/complaint other

1.4

11.0

491

3560

L73.0

ICD-10 Finland

Acne keloid

43.2

10.9

A10AD01

ATC

insulin (human); parenteral

2.3

10.9

337

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.4

10.9

509

3718

P06

ICPC

Sleep disturbance

1.3

10.9

734

5678

H04AA01

ATC

glucagon; nasal, parenteral

1.7

10.9

179

1038

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

10.9

391

2724

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.4

10.8

624

4714

L08.0

ICD-10 Finland

Pyoderma

2.7

10.8

207

-1, ,

NOMESCO Finland

1.2

10.8

2222

19574

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

10.8

1071

8717

WX872

NOMESCO Finland

Intensive care

2.0

10.8

108

533

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.4

10.8

283

E000006, ,

ATC

1.6

10.8

251

1592

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.5

10.8

309

2055

N05AB03

ATC

perphenazine; systemic, rectal

1.9

10.7

130

686

CKD40

NOMESCO Finland

Endophotocoagulation of retina

3.2

10.7

133

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.7

10.7

175

1014

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.5

10.7

255

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

10.6

1852

16042

A04AA01

ATC

ondansetron; systemic, rectal

1.6

10.6

250

1591

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

10.6

217

1334

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

10.6

495

3615

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

0.8

10.6

922

11248

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

10.6

206

1251

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

10.5

318

2138

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.7

10.5

203

1229

ZXA05

NOMESCO Finland

Left side

1.4

10.5

561

4189

WX402

NOMESCO Finland

General anaesthesia

1.3

10.5

935

7511

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

10.4

219

1355

R06AE09

ATC

levocetirizine; oral

1.3

10.4

753

5879

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

10.4

2706

24348

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.7

10.4

170

984

S76

ICPC

Skin infection other

1.7

10.4

192

1150

ZXA10

NOMESCO Finland

Bilateral

1.4

10.4

554

4135

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

4.6

10.4

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

10.3

152

853

D19

ICPC

Teeth/gum symptom/complaint

1.2

10.3

1814

15715

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

10.3

1129

9294

QDH05

NOMESCO Finland

Correction of deformity of toe nail

7.7

10.3

A10AC01

ATC

insulin (human); parenteral

1.6

10.3

268

1745

ZXA00

NOMESCO Finland

Right side

1.4

10.3

604

4574

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

3.0

10.3

152

K30

ICD-10 Finland

Functional dyspepsia

1.4

10.3

461

3343

P74

ICPC

Anxiety disorder/anxiety state

1.4

10.3

423

3022

A05

ICPC

Feeling ill

1.3

10.3

654

5016

L50.3

ICD-10 Finland

Dermatographic urticaria

2.1

10.2

483

J01EA01

ATC

trimethoprim; systemic

1.3

10.2

980

7939

L17

ICPC

Foot/toe symptom/complaint

1.2

10.2

1352

11369

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.5

10.1

331

2263

J35.0

ICD-10 Finland

Chronic tonsillitis

1.4

10.1

419

2996

J05AB11

ATC

valaciclovir; oral

1.4

10.1

533

3972

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

2.1

10.1

446

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

10.1

161

927

W85

ICPC

Gestational diabetes

0.6

10.1

190

3023

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.5

10.0

245

G04BD04

ATC

oxybutynin; oral, transdermal

1.9

10.0

122

646

W90

ICPC

Uncompl labour/delivery livebirth

0.7

10.0

262

3877

L05.0

ICD-10 Finland

Pilonidal cyst with abscess

2.2

10.0

350

R55

ICD-10 Finland

Syncope and collapse

1.5

10.0

330

2262

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.7

9.9

163

945

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

9.9

400

2846

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

9.9

774

6107

N02AA05

ATC

oxycodone; systemic

1.5

9.9

292

1955

WZB00, ,

SPAT

1.3

9.9

1028

8407

J01DA09

ATC

[U] cefadroxil

1.3

9.9

1047

8581

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.4

9.9

543

4073

J01CF05

ATC

flucloxacillin; systemic

1.5

9.8

327

2243

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

9.8

960

7794

SPAT1379

SPAT

Health check-up of pregnant person

0.8

9.8

744

9248

R02

ICPC

Shortness of breath/dyspnoea

1.4

9.8

511

3800

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.6

9.8

201

L04AB06

ATC

golimumab; parenteral

2.6

9.8

207

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

9.7

225

1426

R01AD09

ATC

mometasone; nasal

1.2

9.7

2266

20138

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

9.7

941

7629

N06BA04

ATC

methylphenidate; oral

1.4

9.7

423

3052

R00.2

ICD-10 Finland

Palpitations

1.4

9.7

387

2749

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.6

9.7

241

1554

R03BA02

ATC

budesonide; inhalant

1.3

9.6

778

6167

A06AC51

ATC

ispaghula, combinations; oral

1.8

9.6

136

756

X58

ICD-10 Finland

Exposure to other specified factors

1.3

9.6

780

6187

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.6

9.5

204

1269

R01AD12

ATC

fluticasone furoate; nasal

1.2

9.5

1798

15657

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

9.5

215

1356

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

9.5

374

2651

L84

ICD-10 Finland

Corns and callosities

2.0

9.5

105

539

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.8

9.5

165

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

2.5

9.5

240

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

4.6

9.4

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

9.4

196

1212

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.8

9.4

1093

12920

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.9

9.4

117

625

H05BX02

ATC

paricalcitol; systemic

29.9

9.4

L03

ICPC

Low back symptom/complaint

1.2

9.4

1435

12238

SPAT1380

SPAT

Postpartum check-up

0.8

9.4

590

7523

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.8

9.4

146

835

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

17.4

9.4

L90.6

ICD-10 Finland

Striae atrophicae

3.8

9.3

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.5

9.2

249

1638

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

9.2

304

2086

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.4

9.1

244

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

9.1

387

2779

D10AE01

ATC

benzoyl peroxide; topical

13.6

9.1

N03AE01

ATC

clonazepam; systemic

1.7

9.1

163

969

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

4.1

9.1

205

Kela drug reimbursment

Chronic hypertension

1.5

9.1

264

1763

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.6

9.1

230

1491

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

1.9

9.0

102

527

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

9.0

394

2844

XKC03

NOMESCO Finland

Water cystometry

2.3

9.0

295

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

9.0

241

1581

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

1.7

9.0

148

860

L71.1

ICD-10 Finland

Rhinophyma

36.5

9.0

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

9.0

231

1502

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.4

9.0

234

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

9.0

J45.1

ICD-10 Finland

Nonallergic asthma

1.5

9.0

290

1980

ZYC02, ,

SPAT

1.4

8.9

487

3647

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.7

8.9

158

937

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

2.3

8.9

284

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

8.9

240

1577

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

8.9

415

3030

QBE05

NOMESCO Finland

Excision of sweat glands or sweat gland bearing skin from trunk

18.5

8.9

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

8.9

186

1152

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

8.9

727

5769

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

3.4

8.8

H00.1

ICD-10 Finland

Chalazion

1.7

8.8

171

1039

ZYC01, ,

SPAT

1.3

8.8

803

6458

C07AB02

ATC

metoprolol; systemic

1.5

8.8

318

2219

L28.1

ICD-10 Finland

Prurigo nodularis

4.3

8.8

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.9

8.8

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

8.8

322

2254

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

4.6

8.7

C10AA05

ATC

atorvastatin; oral

1.3

8.7

644

5040

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

8.7

296

2041

A07AA09

ATC

vancomycin; oral

2.7

8.7

167

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

8.7

2277

20382

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

1.7

8.7

149

876

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

8.7

2034

18033

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

8.7

422

3104

M79.7

ICD-10 Finland

Fibromyalgia

1.7

8.7

140

810

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.0

8.7

466

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

8.6

716

5688

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

0.8

8.6

726

8922

R61.0

ICD-10 Finland

Localized hyperhidrosis

2.8

8.6

151

TK820

NOMESCO Finland

Peritoneal dialysis

4.1

8.6

A10AE06

ATC

insulin degludec; parenteral

1.7

8.6

151

893

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.3

8.6

492

3710

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.7

8.6

144

841

D07AA02

ATC

hydrocortisone; topical

1.3

8.6

807

6511

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.5

8.6

197

EBA10

NOMESCO Finland

Operative extraction of tooth

1.2

8.6

1197

10098

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.4

8.6

474

3557

B01AC04

ATC

clopidogrel; oral

1.7

8.6

165

1001

X15

ICPC

Vaginal symptom/complaint other

1.4

8.6

347

2473

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

8.5

448

3334

A07EA02

ATC

hydrocortisone; rectal

2.1

8.5

367

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.8

8.5

132

754

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.7

8.5

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

8.5

190

1196

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.6

8.5

184

1150

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

8.5

101

532

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

1.8

8.4

118

654

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.2

8.4

291

H29

ICPC

Ear symptom/complaint other

1.4

8.4

445

3315

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

8.4

273

1865

F34.1

ICD-10 Finland

Dysthymia

1.6

8.4

200

1278

R60.0

ICD-10 Finland

Localized oedema

1.5

8.4

296

2055

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.8

8.4

118

655

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

8.4

228

1501

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

2.0

8.4

430

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

8.4

640

5029

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

8.4

769

6186

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

2.4

8.4

236

KMAK, ,

NOMESCO Finland

1.2

8.3

2472

22334

G43.9

ICD-10 Finland

Migraine, unspecified

1.4

8.3

456

3416

7061X

ICD-9 Finland

Diseases of sebaceous glands, Other acne[ACNE ALIA DEFINITA]

+∞

8.3

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

1.7

8.3

157

948

UJH02

NOMESCO Finland

Anoscopy

1.9

8.3

515

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.4

8.3

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

8.3

106

572

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.8

8.3

747

9106

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.5

8.3

232

1539

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

8.2

450

3370

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

8.2

338

2414

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

3.2

8.2

R52.2

ICD-10 Finland

Other chronic pain

1.7

8.2

133

771

ZXC07

NOMESCO Finland

Carbon dioxide laser

14.4

8.2

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

2.8

8.2

139

D09AB01

ATC

zinc bandage without supplements; topical

2.3

8.1

239

S01

ICPC

Pain/tenderness of skin

1.6

8.1

189

1202

F31.8

ICD-10 Finland

Other bipolar affective disorders

1.7

8.1

130

751

N06BA12

ATC

lisdexamfetamine; oral

1.7

8.1

138

811

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

8.1

758

6113

XKD00

NOMESCO Finland

Uroflowmetry

1.5

8.1

238

1595

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

8.0

168

1041

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.2

8.0

297

ZY010

NOMESCO Finland

Hospital outpatient

1.4

8.0

364

2645

L93.0

ICD-10 Finland

Discoid lupus erythematosus

4.5

8.0

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

8.0

125

716

XF404

NOMESCO Finland

Ambulatory ECG

1.5

8.0

210

1372

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

8.0

1480

12818

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

8.0

331

2367

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

8.0

174

1089

SAA04

NOMESCO Finland

Special examination of mouth

1.4

8.0

359

2605

J01CA08

ATC

pivmecillinam; oral

1.2

8.0

1866

16504

D07AB01

ATC

clobetasone; topical

1.8

8.0

107

586

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.2

8.0

311

M05BA04

ATC

alendronic acid; oral

2.0

8.0

411

CKC12

NOMESCO Finland

Photocoagulation of retina

1.8

8.0

104

565

WX290

NOMESCO Finland

Other blockage of nerve

1.2

8.0

3087

28471

Z2446

NOMESCO Finland

Social worker

1.4

7.9

333

2388

N03AX11

ATC

topiramate; oral

1.7

7.9

131

763

C09AA02

ATC

enalapril; systemic

1.5

7.9

269

1855

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.0

7.9

405

D01

ICPC

Abdominal pain/cramps general

1.3

7.9

830

6782

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.3

7.9

467

3541

D12

ICPC

Constipation

1.8

7.9

120

683

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

2.5

7.9

182

D06BB04

ATC

podophyllotoxin; topical

1.4

7.9

313

2224

SPAT1146

SPAT

Puncture of abscess or incision of skin

2.3

7.9

249

Z00.0

ICD-10 Finland

General medical examination

1.2

7.9

929

7693

L73

ICD-10 Finland

Other follicular disorders

4.2

7.9

L64.9

ICD-10 Finland

Androgenic alopecia, unspecified

4.2

7.9

ZXE00

NOMESCO Finland

One hour or less

1.2

7.9

1556

13560

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

7.9

324

2317

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

3.4

7.9

XCK00

NOMESCO Finland

Perimetry

1.7

7.8

125

721

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

1.9

7.8

448

WX307

NOMESCO Finland

Obstetric epidural analgesia

0.8

7.8

537

6778

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.4

7.8

416

3106

R06AX22

ATC

ebastine; oral

1.3

7.8

688

5509

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

7.8

159

981

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.4

7.8

362

2644

N04BC05

ATC

pramipexole; oral

1.7

7.8

142

851

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

7.8

585

4589

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

7.8

178

1129

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

7.8

655

5214

C09CA06

ATC

candesartan; oral

1.3

7.8

668

5331

RS221, ,

NOMESCO Finland

2.2

7.7

276

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.2

7.7

270

Z50.1

ICD-10 Finland

Other physical therapy

1.7

7.7

126

732

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.4

7.7

308

2190

A07EC01

ATC

sulfasalazine; oral, rectal

1.5

7.7

255

1750

Z94.4

ICD-10 Finland

Liver transplant status

3.8

7.7

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.9

7.7

116

E000003, ,

ATC

1.6

7.7

184

1179

MAX99

NOMESCO Finland

Assistance to normal delivery

0.8

7.7

478

6113

SPAT1312

SPAT

General health counselling

1.2

7.7

1918

17050

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

1.5

7.7

199

1299

SPAT1307

SPAT

Psychosocial counselling and guidance

1.3

7.7

649

5169

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.4

7.6

409

3055

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.6

3736

35056

E10

ICD-10 Finland

Type 1 diabetes mellitus

1.8

7.6

114

646

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

7.6

2821

25879

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

1.9

7.6

502

R33

ICD-10 Finland

Retention of urine

1.7

7.6

121

698

N02CD02

ATC

galcanezumab; parenteral

2.6

7.6

156

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.4

7.6

340

2467

H3601, E103,

ICD-10 Finland

2.4

7.6

216

I70.0

ICD-10 Finland

Atherosclerosis of aorta

24.9

7.5

Z01.7

ICD-10 Finland

Laboratory examination

1.3

7.5

726

5872

L64.8

ICD-10 Finland

Other androgenic alopecia

11.8

7.5

R01AD08

ATC

fluticasone; nasal

1.2

7.5

1241

10626

3007

Kela drug reimbursment

Erenumab and fremanezumab

1.9

7.5

511

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

7.5

220

1473

WYA10

NOMESCO Finland

Emergency care or similar visit

1.4

7.5

392

2916

EBA00

NOMESCO Finland

Extraction of tooth

1.2

7.5

2152

19336

A04

ICPC

Weakness/tiredness general

1.2

7.5

908

7537

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

10.0

7.5

K59.0

ICD-10 Finland

Constipation

1.5

7.5

199

1306

R04.0

ICD-10 Finland

Epistaxis

1.6

7.5

178

1140

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.0

7.5

387

J05AB01

ATC

aciclovir; systemic

1.2

7.5

809

6634

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

7.4

238

1623

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

7.4

534

4161

XCD20

NOMESCO Finland

Photoangiography of eye

3.2

7.4

L72

ICD-10 Finland

Follicular cysts of skin and subcutaneous tissue

3.3

7.4

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

2.1

7.4

314

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.2

7.4

256

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

1.7

7.4

135

810

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

2.0

7.3

362

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

7.3

248

1710

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

7.3

352

2584

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.5

7.3

252

1744

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

7.3

337

2457

R39.1

ICD-10 Finland

Other difficulties with micturition

2.0

7.3

390

E87.5

ICD-10 Finland

Hyperkalaemia

3.3

7.3

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.9

7.3

109

H40.0

ICD-10 Finland

Glaucoma suspect

1.7

7.3

136

820

N94.1

ICD-10 Finland

Dyspareunia

1.7

7.3

134

805

L70.3

ICD-10 Finland

Acne tropica

+∞

7.3

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

7.3

517

OAA10, ,

SPAT

0.7

7.3

342

4557

JL9AE

NOMESCO Finland

Ultrasound examination of pancreas transplant

10.8

7.3

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.8

7.3

106

597

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

1.6

7.2

164

1038

K61.0

ICD-10 Finland

Anal abscess

1.9

7.2

426

H10

ICD-10 Finland

Conjunctivitis

1.3

7.2

456

3490

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

7.2

529

4133

R19.5

ICD-10 Finland

Other faecal abnormalities

2.1

7.2

291

J01MA14

ATC

moxifloxacin; systemic

1.5

7.2

216

1454

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

7.2

541

4241

J20

ICD-10 Finland

Acute bronchitis

1.3

7.2

410

3092

G93.3

ICD-10 Finland

Postviral fatigue syndrome

2.6

7.2

149

L72.9

ICD-10 Finland

Follicular cyst of skin and subcutaneous tissue, unspecified

3.8

7.2

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

1.8

7.2

111

636

R83

ICPC

Respiratory infection other

1.2

7.2

1864

16601

H10.5

ICD-10 Finland

Blepharoconjunctivitis

1.9

7.2

484

N19

ICD-10 Finland

Unspecified kidney failure

2.4

7.2

203

WZC30, ,

SPAT

1.4

7.2

259

1810

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.0

7.1

332

K02.1

ICD-10 Finland

Caries of dentine

1.2

7.1

3519

32933

A03CA02

ATC

clidinium and psycholeptics; oral

2.0

7.1

339

N92.5

ICD-10 Finland

Other specified irregular menstruation

1.4

7.1

315

2281

S01GX08

ATC

ketotifen; ophthalmic

1.5

7.1

246

1704

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

1.8

7.1

528

R06.5

ICD-10 Finland

Mouth breathing

1.4

7.1

315

2282

RJ425, ,

NOMESCO Finland

19.9

7.1

OAB42, ,

SPAT

1.2

7.1

796

6551

D11AH01

ATC

tacrolimus; topical

2.0

7.1

374

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

1.6

7.1

139

850

J30.3

ICD-10 Finland

Other allergic rhinitis

1.5

7.1

210

1412

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

6.5

7.1

D06BB10

ATC

imiquimod; topical

1.5

7.1

209

1404

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

0.8

7.1

447

5706

H70

ICPC

Otitis externa

1.8

7.1

551

H81

ICPC

Excessive ear wax

1.3

7.1

418

3171

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

1.9

7.1

416

SPAT1229

SPAT

Assessment of need for aid

1.7

7.0

121

714

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

7.0

131

790

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

1.6

7.0

169

1085

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

7.0

515

4025

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.6

7.0

172

1109

A54.0

ICD-10 Finland

Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess

3.3

7.0

TAB00

NOMESCO Finland

Lumbar puncture

1.5

7.0

180

1173

KBV10

NOMESCO Finland

Removal of stent from ureter

3.0

7.0

101

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.5

7.0

175

L30.8

ICD-10 Finland

Other specified dermatitis

1.7

7.0

117

686

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

7.0

128

769

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.0

7.0

342

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.6

7.0

163

1040

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.8

7.0

123

L04AC05

ATC

ustekinumab; parenteral

2.6

7.0

140

C08CA01

ATC

amlodipine; oral

1.3

7.0

559

4421

R05

ICPC

Cough

1.2

7.0

1231

10601

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.1

6.9

276

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

6.9

359

2669

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

3.8

6.9

A01AB04

ATC

amphotericin B; local oral

2.1

6.9

303

F29

ICPC

Eye symptom/complaint other

1.3

6.9

487

3787

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.4

6.9

273

1940

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

4.3

6.9

N06AX05

ATC

trazodone; oral

1.8

6.9

548

C10AX09

ATC

ezetimibe; oral

1.4

6.9

252

1765

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.4

6.9

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

3.2

6.9

M01CB01

ATC

sodium aurothiomalate; parenteral

3.3

6.9

A10AA03, ,

ATC

2.6

6.9

141

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

1.5

6.9

191

1267

L92.1

ICD-10 Finland

Necrobiosis lipoidica, not elsewhere classified

5.4

6.9

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.4

6.9

243

1692

ZQX00

NOMESCO Finland

0-4% of the skin

7.5

6.9

S22

ICPC

Nail symptom/complaint

1.4

6.9

270

1917

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.3

6.8

387

2916

K80

ICPC

Cardiac arrhythmia NOS

1.5

6.8

234

1620

G04CA02

ATC

tamsulosin; oral

1.4

6.8

281

2012

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.9

6.8

464

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.2

6.8

259

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

6.8

860

7168

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.3

6.8

469

3637

N02CD01

ATC

erenumab; parenteral

2.1

6.8

292

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.3

6.8

423

3234

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

10.9

6.8

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

6.7

391

2957

H57.1

ICD-10 Finland

Ocular pain

1.5

6.7

199

1337

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

39.8

6.7

D16

ICPC

Rectal bleeding

1.8

6.7

102

582

XPX08

NOMESCO Finland

Intraoperative flow measurement

5.6

6.7

H3600, E103,

ICD-10 Finland

2.0

6.7

320

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.4

6.7

356

2657

H26.2

ICD-10 Finland

Complicated cataract

2.8

6.7

109

A03FA02

ATC

cisapride; oral, rectal

1.5

6.7

169

1098

SPAT1254

SPAT

Administration of medicine

1.2

6.7

772

6373

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

6.7

319

2342

G43

ICD-10 Finland

Migraine

1.3

6.6

443

3418

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.8

6.6

540

Z37.0

ICD-10 Finland

Single live birth

0.7

6.6

372

4829

K08.80

ICD-10 Finland

Toothache NOS

1.3

6.6

466

3622

A07EA06

ATC

budesonide; oral, local oral

1.6

6.6

161

1037

R03DC03

ATC

montelukast; oral

1.2

6.6

707

5784

N05AA01

ATC

chlorpromazine; systemic, rectal

2.6

6.6

138

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

2.9

6.6

L30.4

ICD-10 Finland

Erythema intertrigo

2.3

6.6

217

C02AC05

ATC

moxonidine; oral

2.1

6.6

282

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.6

6.6

155

991

H53.1

ICD-10 Finland

Subjective visual disturbances

1.4

6.6

254

1797

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.6

6.6

144

905

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

6.6

1212

10469

P01BA02

ATC

hydroxychloroquine; oral

1.5

6.6

222

1532

A28

ICPC

Limited function/disability NOS

1.4

6.6

233

1623

K03.0

ICD-10 Finland

Excessive attrition of teeth

1.7

6.6

117

698

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

6.6

115

683

R13

ICD-10 Finland

Dysphagia

1.5

6.6

168

1095

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

6.6

448

J01FA09

ATC

clarithromycin; systemic

1.2

6.6

1323

11519

XF402

NOMESCO Finland

ECG with work load test

1.5

6.6

172

1127

A12AA12

ATC

[U] calcium acetate

12.2

6.6

K51.8

ICD-10 Finland

Other ulcerative colitis

2.0

6.5

330

F33

ICD-10 Finland

Recurrent depressive disorder

1.5

6.5

174

1144

SFA30

NOMESCO Finland

Three-surface restoration

1.2

6.5

1530

13491

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

8.6

6.5

IHZ05, ,

SPAT

1.3

6.5

475

3711

JLE70

NOMESCO Finland

Inspection and preparation of pancreas, pre-transplantation

10.0

6.5

D11AH02

ATC

pimecrolimus; topical

2.5

6.5

157

N05AD01

ATC

haloperidol; systemic

1.9

6.5

393

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

6.5

805

6693

N75.8

ICD-10 Finland

Other diseases of Bartholin gland

3.3

6.5

L13.0

ICD-10 Finland

Dermatitis herpetiformis

3.8

6.5

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

1.8

6.5

479

R07.0

ICD-10 Finland

Pain in throat

1.3

6.5

486

3812

R61

ICD-10 Finland

Hyperhidrosis

2.3

6.5

213

SPAT1255

SPAT

Intravenous administration of medicine

1.5

6.4

166

1084

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

6.4

348

2605

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

6.4

552

4402

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

6.4

141

887

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

0.7

6.4

354

4608

L04AB02

ATC

infliximab; parenteral

2.3

6.4

207

F48.0

ICD-10 Finland

Neurasthenia

6.1

6.4

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

6.4

342

2555

R22.3

ICD-10 Finland

Localized swelling, mass and lump, upper limb

1.8

6.4

495

A01

ICPC

Pain general/multiple sites

1.3

6.4

352

2642

ZZA00

NOMESCO Finland

Split skin graft

2.2

6.4

233

J96.1

ICD-10 Finland

Chronic respiratory failure

2.9

6.4

101

TQX05

NOMESCO Finland

Skin puncture, unspecified location

3.9

6.4

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

6.4

158

1023

R4180

NOMESCO Finland

Podiatric therapy

2.6

6.4

135

G47.3

ICD-10 Finland

Sleep apnoea

1.3

6.4

610

4930

H60.3

ICD-10 Finland

Other infective otitis externa

1.8

6.4

540

L85.81

ICD-10 Finland

Keratosis pilaris

2.7

6.4

118

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.7

6.4

118

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.3

6.3

512

4052

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.5

6.3

147

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

1.8

6.3

446

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.4

6.3

159

R35

ICD-10 Finland

Polyuria

1.5

6.3

157

1018

N07BA03

ATC

varenicline; oral

1.5

6.3

176

1170

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

2.3

6.3

203

SFA20

NOMESCO Finland

Two-surface restoration

1.2

6.3

3040

28275

K50.0

ICD-10 Finland

Crohn disease of small intestine

1.9

6.3

405

D94

ICPC

Chronic enteritis/ulcerative colitis

2.4

6.3

172

R03BA01

ATC

beclometasone; inhalant

1.3

6.3

400

3069

ZZR00

NOMESCO Finland

Flap of skin

2.7

6.3

119

S92

ICPC

Sweat gland disease

9.2

6.3

C01CA24

ATC

epinephrine; parenteral

1.3

6.2

340

2548

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

6.2

391

2991

QAE50

NOMESCO Finland

Dermabrasion of superficial lesion of skin of head or neck

17.9

6.2

7062A

ICD-9 Finland

Diseases of sebaceous glands, Sebaceous cyst[CYSTA SEBACEA (ATHEROMA)]

+∞

6.2

7061E

ICD-9 Finland

Diseases of sebaceous glands, Other acne[ACNE CONGLOBATA]

+∞

6.2

70600

ICD-8 Finland

Diseases of sebaceous glands, Acne necrotica

+∞

6.2

B01AA03

ATC

warfarin; systemic

1.5

6.2

190

1286

P76

ICPC

Depressive disorder

1.3

6.2

478

3759

R51

ICD-10 Finland

Headache

1.3

6.2

339

2542

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

6.2

1562

13841

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.6

6.2

131

Z39.2

ICD-10 Finland

Routine postpartum follow-up

0.8

6.2

921

10687

R30.0

ICD-10 Finland

Dysuria

1.5

6.2

203

1395

R4120

NOMESCO Finland

Occupational therapy

1.5

6.2

202

1387

SXC05

NOMESCO Finland

Other oral or dental procedure

1.3

6.2

507

4022

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

6.2

101

590

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

6.1

116

704

R20.2

ICD-10 Finland

Paraesthesia of skin

1.4

6.1

305

2255

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.5

6.1

190

1291

XA402

NOMESCO Finland

ENMG

2.0

6.1

311

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

2.4

6.1

168

321

Kela drug reimbursment

Paricalcitol and cinacalcet

3.9

6.1

K03.2

ICD-10 Finland

Erosion of teeth

1.8

6.1

488

SPAT1197

SPAT

Extensive health check-up of expecting family

0.8

6.1

874

10178

L04AB05

ATC

certolizumab pegol; parenteral

2.5

6.1

144

K10.3

ICD-10 Finland

Alveolitis of jaws

1.4

6.1

265

1916

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

6.1

498

3948

3029

Kela drug reimbursment

Upadacitinib

2.9

6.1

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.4

6.1

300

2215

H03AA01

ATC

levothyroxine sodium; systemic

1.2

6.1

707

5838

R74

ICPC

Upper respiratory infection acute

1.2

6.1

2435

22329

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

1.9

6.0

375

C08CA02

ATC

felodipine; oral

1.7

6.0

100

586

WW400

NOMESCO Finland

Plasmaferesis

4.1

6.0

SPAT1325

SPAT

Vaccination

1.2

6.0

1388

12208

L02.1

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of neck

2.4

6.0

163

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

2.4

6.0

151

188

Kela drug reimbursment

Psychosis requiring demanding treatment

2.7

6.0

116

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1198

6905

1.92

79.17

3.6

2.4

6114.69

7178.10

u/l

0.43

304

2871

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4579

38899

1.96

78.47

4.2

3.0

1.18

1.19

mmol/l

0.59

4444

37253

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

863

4694

1.98

66.51

3.1

1.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3684

30030

1.65

64.49

9.2

6.7

73.08

73.87

u/l

0.66

3530

28559

(3006315) Basophils [#/volume] in Blood

3018

23449

1.61

64.06

8.6

6.5

0.04

e9/l

0.68

2737

20620

(3001604) Monocytes [#/volume] in Blood

3015

23446

1.61

63.54

8.5

6.5

0.54

e9/l

0.07

2735

20641

(3013115) Eosinophils [#/volume] in Blood

3096

24264

1.61

62.87

9.1

6.7

0.18

e9/l

0.42

2832

21650

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4776

42079

1.91

60.36

4.8

3.5

4.53

4.62

mmol/l

10.22

4652

40513

(3007853) Bacteria identified in Skin by Aerobe culture

881

4988

1.90

59.75

2.2

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5281

48390

2.66

59.31

12.9

8.6

25.41

26.54

u/l

3.58

5212

47248

(3019198) Lymphocytes [#/volume] in Blood

3081

24340

1.58

58.66

8.6

6.4

1.98

2.03

e9/l

2.20

2845

21945

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2549

19568

1.54

52.97

2.9

2.5

72.01

69.62

nmol/l

4.05

2433

18538

(3013650) Neutrophils [#/volume] in Blood by Automated count

3228

26096

1.55

52.95

11.4

8.8

3.94

3.98

e9/l

0.50

2912

22783

(42870588) Differential panel, method unspecified - Blood

2002

14704

1.55

49.95

8.1

6.7

—

3.75

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3761

31689

1.56

49.23

4.8

3.7

8.41

7.97

mm/h

1.68

3586

29920

(3019069) Monocytes/Leukocytes in Blood

2743

21637

1.51

48.68

8.5

6.6

8.29

0.06

2637

20499

(3006504) Eosinophils/Leukocytes in Blood

2729

21580

1.51

47.34

8.5

6.5

2.68

2.75

1.15

2616

20420

(3024561) Albumin [Mass/volume] in Serum or Plasma

2012

14963

1.53

46.55

6.7

4.9

37.74

37.69

g/l

0.16

1903

14096

(3022096) Basophils/Leukocytes in Blood

2717

21529

1.50

46.25

8.6

6.6

0.68

0.66

1.27

2602

20338

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2195

16667

1.51

45.82

9.0

6.3

1.22

1.21

mmol/l

2.01

1930

14574

(3048689) Calprotectin [Mass/mass] in Stool

1290

8702

1.62

45.64

3.2

2.9

123.44

106.68

ug/g

0.87

1016

6872

(3018010) Neutrophils/Leukocytes in Blood

2795

22347

1.49

45.04

8.2

6.3

55.55

55.53

0.03

2711

21555

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2080

15707

1.51

44.10

2.2

1.7

1.29

1.33

mmol/l

1.51

1910

14084

(3002030) Lymphocytes/Leukocytes in Blood

2830

22746

1.48

44.01

8.4

6.4

30.17

30.50

0.96

2736

21775

(3037522) Nuclear Ab [Titer] in Serum

1047

6830

1.65

41.96

1.5

1.4

562.83

514.80

titre

0.30

184

1261

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1677

12211

1.52

41.75

3.8

2.5

57.63

57.27

u/l

0.07

1557

11385

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1950

14675

1.49

41.32

8.4

6.1

1.22

1.21

mmol/l

2.12

1826

13713

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2419

19011

1.47

41.14

6.1

5.4

9.82

10.33

umol/l

2.18

2284

17873

(3018418) pH of Serum or Plasma

1366

9613

1.55

39.37

5.9

3.7

7.39

0.84

975

6464

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4686

42265

1.65

39.21

4.5

3.7

2.70

2.78

mmol/l

10.27

4518

40515

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1569

11404

1.51

38.82

2.5

2.3

2.51

mg/l

0.01

1372

9949

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2027

15537

1.47

38.42

1.6

1.4

1.84

1.72

u/ml

0.16

632

4355

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4646

41931

1.62

37.42

4.2

3.4

1.44

1.43

mmol/l

0.41

4489

40235

(3007164) IgA [Mass/volume] in Serum or Plasma

1769

13280

1.48

36.94

1.5

2.08

2.05

g/l

0.42

1180

8754

(3022948) Iron [Moles/volume] in Serum or Plasma

940

6192

1.61

35.61

3.3

2.3

14.75

14.97

umol/l

0.38

895

5807

(3042936) Bacteria identified in Isolate by Culture

788

4968

1.67

35.53

2.4

1.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4752

43297

1.62

34.79

15.0

10.2

3.91

3.89

mmol/l

2.97

4658

42044

(3015377) Calcium [Moles/volume] in Serum or Plasma

1577

11706

1.47

34.34

3.1

2.8

2.35

mmol/l

0.01

1458

10909

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1934

14977

1.44

33.47

1.9

1.8

98.40

97.65

pmol/l

0.33

1094

8587

(3019550) Sodium [Moles/volume] in Serum or Plasma

4737

43236

1.60

33.16

14.8

10.1

139.48

139.51

mmol/l

0.64

4662

42108

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4268

38112

1.49

32.84

4.9

4.3

14.44

14.36

pmol/l

1.49

4009

35298

(3003458) Phosphate [Moles/volume] in Serum or Plasma

701

4405

1.67

31.78

10.8

6.6

1.09

1.08

mmol/l

0.14

667

4134

(3004789) Transferrin [Mass/volume] in Serum or Plasma

852

5642

1.59

31.21

3.4

2.3

2.42

2.51

g/l

4.49

797

5231

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

775

5056

1.61

30.14

3.6

2.4

23.98

24.25

0.23

736

4718

(3017446) Testosterone [Moles/volume] in Serum or Plasma

682

4311

1.65

30.12

2.6

2.2

10.42

11.85

nmol/l

3.61

619

3988

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1933

15186

1.41

29.99

3.7

3.2

30.37

29.56

u/l

0.27

1831

14501

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3333

28674

1.39

29.81

3.9

3.3

70.65

69.80

ug/l

0.15

3194

27391

(3000494) Fungus identified in Specimen by Culture

754

4907

1.61

29.59

1.6

1.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1266

9237

1.47

29.30

2.4

2.2

193.71

234.86

u/l

0.54

1209

8838

(40760892) CBC W Ordered Manual Differential panel - Blood

1609

12325

1.42

28.52

5.8

4.1

—

(3021589) Normoblasts [#/volume] in Blood

2545

21161

1.36

27.01

11.9

9.3

0.00

e9/l

0.79

2127

17313

(3032080) INR in Blood by Coagulation assay

1694

13191

1.40

26.99

9.4

6.7

1.10

1.09

inr

0.75

1424

10982

(3021960) Folate [Moles/volume] in Serum or Plasma

1251

9231

1.45

26.97

1.6

1.5

19.81

19.28

nmol/l

0.56

1144

8338

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4707

43404

1.51

26.05

5.9

5.0

1.71

1.74

mu/l

1.01

4544

41530

(3036481) Cortisol [Moles/volume] in Serum or Plasma

698

4638

1.57

24.80

2.2

2.1

392.73

388.44

nmol/l

0.21

651

4327

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

413

2410

1.76

24.32

1.9

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

788

5406

1.52

24.19

5.2

4.2

0.82

0.83

mmol/l

2.28

753

5164

(3017732) Neutrophils [#/volume] in Blood

782

5367

1.52

23.94

3.0

2.7

4.04

4.57

e9/l

2.88

702

4822

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5116

48245

1.67

23.81

16.7

11.1

72.00

69.55

umol/l

6.68

5070

47669

(3020779) Urea [Moles/volume] in Serum or Plasma

451

2715

1.71

23.76

15.0

8.2

8.13

6.65

mmol/l

5.94

443

2615

(3015171) Extractable nuclear Ab [Units/volume] in Serum

335

1861

1.84

23.24

1.3

0.26

1.07

u/ml

1.85

123

(3002179) Metamyelocytes/Leukocytes in Blood

528

3353

1.63

22.61

5.5

4.4

0.52

0.56

0.21

164

814

(3019309) Folate [Moles/volume] in Red Blood Cells

643

4287

1.56

22.39

1.7

1.6

1212.06

1136.90

nmol/l

1.15

490

3358

(3015736) pH of Urine

2434

20501

1.32

21.97

3.6

2.9

6.25

6.27

0.28

1381

11465

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4486

41315

1.41

21.88

13.0

8.8

99.55

100.48

ml/min/173m2

2.18

4004

35941

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1450

11318

1.37

21.83

3.0

2.5

102.36

55.68

ng/l

0.29

607

4649

(3022145) Colonoscopy Study observation

615

4098

1.55

21.42

1.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

340

1945

1.79

21.41

2.4

2.1

9.35

7.06

iu/ml

0.66

474

(3021440) Promyelocytes/Leukocytes in Blood

520

3367

1.59

20.49

5.9

4.8

0.08

0.11

0.57

146

734

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5003

47189

1.54

20.15

15.5

10.5

19.38

20.54

mg/l

1.91

4005

36948

(3017181) Myelocytes/Leukocytes in Blood

534

3498

1.57

20.01

5.8

4.7

0.78

0.80

0.05

161

863

(3029937) Albumin [Presence] in Urine by Test strip

1659

13366

1.33

19.92

4.4

3.2

0.01

0.00

estimate

0.16

615

5193

(40758558) Short blood count panel - Blood

1570

12550

1.34

19.89

7.3

5.9

—

(40761535) Cells panel - Urine sediment

389

2361

1.69

19.83

3.7

3.0

—

(3035350) Ketones [Presence] in Urine by Test strip

2912

25353

1.30

19.74

4.2

3.2

0.00

3.79

estimate

3.67

639

5396

(3009261) Glucose [Presence] in Urine by Test strip

2920

25434

1.30

19.72

4.2

3.3

0.00

0.07

estimate

0.54

620

5264

(3021601) Nitrite [Presence] in Urine by Test strip

2887

25115

1.30

19.65

4.2

3.2

0.00

estimate

2.09

641

5425

(40768443) Skin Pathology biopsy report

271

1489

1.85

19.48

1.3

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

355

2114

1.72

19.41

6.7

4.4

99.99

69.81

ng/l

4.79

329

1936

(3013826) Glucose [Moles/volume] in Serum or Plasma

2710

23405

1.30

19.39

5.8

4.6

6.27

6.17

mmol/l

1.26

2500

21004

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2282

19287

1.30

19.19

3.9

3.0

0.02

0.03

estimate

0.65

554

4563

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1107

8463

1.38

18.52

1.4

1.3

52.90

22.22

iu/ml

0.42

284

2142

(3037467) Urinalysis macro (dipstick) panel - Urine

3541

31771

1.30

18.42

5.0

3.9

1.68

18.34

—

(3044889) 12 lead EKG panel

2914

25502

1.29

18.40

3.3

2.7

0.00

18728.95

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

150

680

2.23

18.39

1.2

6.53

6.47

umol/l

0.06

129

615

(3025159) Blasts/Leukocytes in Blood

522

3470

1.55

18.28

6.2

5.0

0.12

0.19

0.23

139

701

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2078

17445

1.29

18.05

2.8

2.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

777

5612

1.44

18.04

2.8

2.4

2.40

mmol/l

0.10

696

5000

(3023368) Bacteria identified in Blood by Culture

1099

8455

1.36

17.56

4.7

3.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3395

30388

1.28

17.50

4.8

3.9

135.19

1597.72

e6/l

4.02

373

(3000850) Epithelial cells [#/volume] in Urine

1092

8397

1.36

17.49

3.7

2.4

6.45

8.25

e6/l

3.06

1002

7535

(3027945) Reticulocytes/Erythrocytes in Blood

495

3293

1.54

17.25

3.7

3.5

1.67

1.65

0.23

443

3000

(3017143) Hepatitis C virus Ab [Presence] in Serum

1317

10462

1.33

16.92

2.0

1.7

—

(40768446) Kidney Pathology biopsy report

192

3.29

16.86

2.3

1.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

222

1200

1.87

16.83

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

647

4576

1.46

16.73

2.8

3.1

5.72

6.55

umol/l

0.89

549

3904

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

348

2151

1.65

16.53

1.9

1.8

45.61

40.02

nmol/l

1.78

343

2121

(3010375) cycloSPORINE [Mass/volume] in Blood

215

3.12

16.49

31.2

27.6

104.64

128.81

ug/l

1.44

179

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2203

18790

1.27

16.40

2.9

2.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1333

10661

1.32

16.22

2.7

2.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

743

5425

1.42

16.13

3.6

3.1

1408.27

602.24

ng/l

2.17

583

4210

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

261

1502

1.76

16.12

2.3

2.1

0.22

g/l

0.14

245

1439

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

887

6679

1.38

16.06

1.7

1.6

103081305.54

36920610.36

pmol/l

1.26

779

5864

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4288

39759

1.32

15.83

3.9

3.3

5.57

5.53

mmol/l

0.83

4068

37607

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

999

7689

1.36

15.73

1.3

7.13

7.98

u/ml

0.23

414

3160

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

235

1321

1.80

15.72

1.3

17.65

39.00

u/ml

1.11

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

265

1547

1.74

15.58

2.3

2.0

1.13

1.17

g/l

1.60

249

1489

(3005322) IgE [Units/volume] in Serum or Plasma

595

4196

1.46

15.57

1.3

260.88

261.96

u/ml

0.01

557

3901

(3019150) Specific gravity of Urine by Refractometry

1468

11959

1.30

15.49

3.9

3.0

1.02

1.56

kg/l

1.35

940

7459

(3023511) Choriogonadotropin [Units/volume] in Urine

523

3604

1.49

15.39

1.7

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

530

3668

1.48

15.26

2.8

2.7

10.98

10.53

g/l

2.11

489

3421

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

379

2441

1.58

15.21

3.4

2.4

78.04

85.07

ml/min/173m2

2.28

183

921

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

728

5366

1.40

14.90

2.0

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

218

1229

1.80

14.47

1.3

18.80

16.60

u/ml

0.09

158

(40768797) Stomach Pathology biopsy report

638

4622

1.42

14.40

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

218

1234

1.79

14.28

1.3

16.27

5.55

u/ml

0.42

103

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

190

1031

1.86

14.28

8.2

6.0

355.39

734.33

iu/ml

0.94

107

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

105

3.90

14.24

2.7

2.8

0.60

0.61

mmol/l

0.35

105

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

470

3219

1.49

14.23

2.5

3.0

0.23

g/l

0.20

445

3021

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

159

814

1.97

14.23

4.8

3.9

1319.63

1345.88

u/ml

—

(36660697) Celiac disease serology panel - Serum

717

5321

1.39

14.05

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

515

3611

1.46

13.85

1.9

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3770

34618

1.26

13.62

3.5

3.0

32.94

32.99

u/l

0.01

3646

33361

(3030467) Casts [#/volume] in Urine by Automated count

1338

10941

1.28

13.38

4.0

2.8

0.29

0.27

e6/l

0.15

995

7609

(3018095) Leukocytes [#/volume] in Urine

1895

16154

1.25

13.38

4.8

3.5

76.75

59.80

e6/l

0.43

1303

10177

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1512

12555

1.27

13.35

2.9

2.3

—

(3026782) Osmolality of Urine

937

7310

1.33

13.26

3.7

2.5

528.44

559.34

mosm/kgh2o

3.56

831

6402

(3033658) Prothrombin time (PT) actual/Normal

1215

9823

1.29

13.25

4.7

4.0

93.83

94.03

0.11

1183

9603

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

521

3711

1.44

12.87

1.9

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1086

8695

1.30

12.69

1.8

1.40

1.36

1.46

978

7884

(3025941) Bacteria identified in Stool by Culture

443

3070

1.47

12.64

1.3

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

1513

12632

1.26

12.63

4.3

2.9

103.47

76.23

e6/l

0.28

1177

9206

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

192

1089

1.78

12.53

1.2

1.3

24.01

45.50

u/ml

0.87

(3023520) Reticulocytes [#/volume] in Blood

348

2300

1.54

12.47

3.3

3.2

73.23

70.97

e9/l

0.50

249

1572

(3048929) Epstein Barr virus Ab [Presence] in Serum

548

3962

1.42

12.45

1.4

1.3

—

(3042733) HLA Ab [Presence] in Serum

161

3.11

12.33

5.5

4.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1201

9781

1.28

12.25

2.3

1.9

0.84

1.00

mg/l

1.68

851

6960

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

471

3325

1.45

12.20

5.0

4.2

—

(3009508) Creatinine [Moles/volume] in Urine

1450

12090

1.26

12.16

4.4

3.5

8.37

8.84

mmol/l

2.46

1326

10930

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4032

37486

1.25

12.16

5.2

4.0

36.50

36.32

mmol/mol

0.62

3880

35974

(3000991) Gas panel - Venous blood

441

3077

1.46

12.15

11.5

9.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2188

19094

1.23

12.11

2.0

1.9

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

4532

42751

1.29

11.97

18.3

13.0

13.20

13.17

1.22

4486

42109

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

492

3519

1.43

11.87

4.8

4.5

226.28

228.18

u/l

0.09

474

3372

(3026008) Bacteria identified in Urine by Culture

1447

12098

1.26

11.79

2.8

2.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

172

965

1.80

11.67

1.3

1.19

3.66

u/ml

0.84

(3028026) IgM [Mass/volume] in Serum or Plasma

407

2822

1.47

11.58

1.7

1.8

1.22

1.27

g/l

0.52

379

2654

(3020630) Protein [Mass/volume] in Serum or Plasma

275

1755

1.59

11.51

2.2

67.55

67.66

g/l

0.08

264

1665

(3002032) Base excess in Venous blood by calculation

465

3310

1.43

11.51

6.4

4.8

1.47

1.52

mmol/l

0.13

400

2833

(3021447) Carbon dioxide [Partial pressure] in Venous blood

475

3396

1.43

11.48

6.3

4.7

5.98

5.87

kpa

1.86

466

3292

(3018677) aPTT in Platelet poor plasma by Coagulation assay

666

5041

1.36

11.44

2.9

2.6

29.53

29.21

0.87

646

4892

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

149

806

1.86

11.38

1.3

—

(3012544) pH of Venous blood

474

3407

1.42

11.12

6.3

4.7

7.36

7.37

1.50

305

2012

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

288

1874

1.56

11.09

1.4

1.3

34.34

44.45

u/ml

—

(3004809) Band form neutrophils/Leukocytes in Blood

469

2.12

11.03

3.2

3.0

1.00

1.46

1.34

428

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

239

1492

1.62

10.98

7.4

6.8

1.43

1.17

mg/l

4.95

231

1407

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

117

596

1.97

10.72

4.4

5.6

0.30

0.34

iu/ml

0.98

304

(3030981) Hyaline casts [#/volume] in Urine by Automated count

378

2624

1.46

10.69

3.4

2.2

0.18

0.30

e6/l

1.46

359

2475

(3000570) Elastase.pancreatic [Mass/mass] in Stool

162

918

1.78

10.66

1.4

1.3

269.47

318.76

ug/g

1.76

432

(3012516) Albumin [Mass/volume] in Urine

946

7594

1.29

10.65

5.1

3.8

68.26

72.64

mg/l

0.17

669

5336

(3004588) Protein electrophoresis panel - Serum or Plasma

202

1220

1.67

10.58

2.0

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

343

2348

1.48

10.42

5.9

3.2

1.22

mmol/l

0.01

293

1999

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

785

9756

0.77

10.40

1.5

1.6

1123.02

1004.22

mu/l

1.93

679

8554

(3009214) Lutropin [Units/volume] in Serum or Plasma

461

3337

1.41

10.38

1.5

1.6

7.28

7.69

u/l

0.44

366

2692

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

282

1857

1.54

10.31

1.1

4.38

4.71

eliau/ml

0.08

288

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

340

2.27

10.24

3.1

3.2

76.84

147.50

au/ml

1.16

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

386

2.18

10.15

4.4

4.2

9.01

9.37

mg/l

0.21

327

(3020682) Albumin/Creatinine [Ratio] in Urine

951

7695

1.28

10.00

6.1

4.5

12.92

11.24

mg/mmol

0.35

671

5359

(3026493) Urate [Moles/volume] in Serum or Plasma

1018

8326

1.26

9.78

3.0

2.4

323.34

318.57

umol/l

0.85

941

7682

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

380

2690

1.43

9.70

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

267

1767

1.53

9.56

1.4

1.3

240.51

222.70

u/ml

0.47

169

1068

(3007461) Platelets [#/volume] in Blood

5422

52927

1.72

9.50

23.4

16.2

263.07

262.12

e9/l

0.56

5362

51957

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

276

2.36

9.48

2.0

2.8

9.90

9.52

mg/l

0.21

239

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

560

4245

1.35

9.48

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

4.41

9.45

5.4

6.6

27.11

26.66

ug/min

0.02

(3014111) Lactate [Moles/volume] in Serum or Plasma

399

2864

1.42

9.43

9.7

8.4

1.20

1.32

mmol/l

2.18

391

2811

(3020961) Endomysium IgA Ab [Titer] in Serum

478

3541

1.37

9.38

1.2

321.14

150.09

titre

0.34

110

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

110

576

1.92

9.36

7.9

3.4

8.66

7.13

pmol/l

1.27

110

576

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

252

1656

1.54

9.33

2.2

7.50

6.76

ug/l

0.22

226

1433

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

105

542

1.94

9.32

1.4

1.2

1085.00

360.51

titre

—

(3000963) Hemoglobin [Mass/volume] in Blood

5426

52992

1.72

9.27

23.5

16.2

136.68

136.81

g/l

0.31

5401

52580

(3026389) Candida sp identified in Specimen by Organism specific culture

142

810

1.76

9.19

1.3

1.2

—

(3035941) MCH [Entitic mass]

5423

52964

1.70

9.14

23.3

16.0

29.95

29.88

2.48

5396

52550

(3024731) MCV [Entitic mean volume] in Red Blood Cells

5422

52952

1.70

9.14

23.3

16.1

89.47

89.18

5.83

5395

52537

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

233

1512

1.56

9.13

1.8

1.4

15.95

20.80

u/ml

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

5423

52965

1.70

9.13

23.8

16.4

40.77

41.14

1.25

5395

52522

(3026361) Erythrocytes [#/volume] in Blood

5423

52968

1.70

9.08

23.3

16.1

4.59

4.60

e12/l

1.51

5357

51934

(3024354) Oxygen [Partial pressure] in Venous blood

403

2921

1.40

9.02

5.0

4.4

4.78

4.80

kpa

0.06

394

2829

(3041096) Erythrocytes [Presence] in Urine by Automated

1733

15101

1.21

9.00

3.3

2.6

0.05

estimate

0.01

554

4527

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

106

560

1.90

8.80

3.0

2.6

314.08

117.09

ug/min

1.24

374

(3003396) Base excess in Arterial blood by calculation

390

2823

1.40

8.80

9.8

9.2

0.24

0.37

mmol/l

0.26

310

2209

(3035933) Granulocytes/Leukocytes in Blood

180

1110

1.63

8.76

4.1

3.3

56.87

56.92

0.02

180

1110

(3010813) Leukocytes [#/volume] in Blood

5423

52991

1.68

8.75

23.4

16.2

6.71

6.78

e9/l

1.76

5351

51927

(3002256) Pathology report gross observation

606

4701

1.32

8.74

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

140

808

1.74

8.72

2.0

2.18

1.84

ug/l

0.17

126

723

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

231

1514

1.54

8.68

1.8

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

662

5203

1.30

8.67

1.3

98.46

142.81

u/ml

2.73

263

1925

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

717

5701

1.29

8.59

3.3

2.9

352.17

456.11

ng/l

0.37

354

2833

(3021387) Prolactin [Units/volume] in Serum or Plasma

601

4670

1.31

8.56

1.7

1.6

324.56

315.07

mu/l

0.27

541

4193

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

391

2846

1.39

8.54

9.7

9.2

5.05

5.01

kpa

0.27

376

2736

(3027801) Oxygen [Partial pressure] in Arterial blood

391

2846

1.39

8.54

9.7

9.2

13.90

14.10

kpa

0.26

377

2736

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

217

1408

1.55

8.53

2.2

1.9

174.47

198.28

pmol/l

1.85

209

1354

(3019977) pH of Arterial blood

393

2866

1.39

8.49

9.8

9.2

7.41

0.05

203

1505

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

420

3098

1.38

8.47

3.4

2.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

333

2364

1.43

8.40

10.8

10.1

122.72

124.26

g/l

0.66

328

2311

(3023323) Follitropin [Units/volume] in Serum or Plasma

571

4419

1.32

8.37

1.5

14.67

15.08

iu/l

0.15

463

3665

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

324

2290

1.43

8.37

4.0

3.9

5.04

5.11

kpa

1.01

313

2199

(3009343) pH of Capillary blood

318

2245

1.43

8.27

4.0

3.9

7.41

0.33

273

1875

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

219

1435

1.54

8.25

1.8

1.5

142.87

137.02

au/ml

0.32

376

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

277

1915

1.46

8.06

1.7

1.6

0.30

0.24

iu/ml

0.09

318

(3016502) Oxygen saturation in Arterial blood

345

2486

1.41

8.01

10.4

9.9

95.84

96.56

0.84

336

2397

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

253

1725

1.48

7.90

1.9

2.0

41.70

39.61

u/l

0.95

240

1629

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

392

2.02

7.90

1.2

1.4

184.20

183.25

pmol/l

0.02

392

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

290

2032

1.44

7.87

1.6

1.7

13.80

9.50

u/ml

0.62

615

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

203

1325

1.54

7.81

1.2

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

206

1349

1.54

7.80

1.5

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

290

2040

1.44

7.71

4.0

3.9

1.15

1.17

mmol/l

0.03

201

1434

(42529406) Shigella sp [Presence] in Stool by Culture

204

1339

1.53

7.66

1.2

1.1

—

(1616796) Gas panel - Central venous blood

131

773

1.70

7.60

6.6

3.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

193

1254

1.55

7.59

2.3

2.2

1.25

1.24

g/l

0.04

177

1106

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

363

4821

0.73

7.55

1.4

1.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

519

1.85

7.49

1.3

0.41

0.39

g/l

0.26

372

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

401

5240

0.74

7.49

1.4

1.5

65.87

61.53

ug/l

1.05

337

4501

(3019420) Tryptase [Mass/volume] in Serum or Plasma

380

2.00

7.47

1.3

1.4

5.68

5.98

ug/l

0.15

342

(3027135) IgG subclass 1 [Mass/volume] in Serum

520

1.85

7.45

1.3

6.56

6.47

g/l

0.09

378

(3028192) IgG subclass 2 [Mass/volume] in Serum

520

1.85

7.45

1.3

3.34

2.91

g/l

1.58

376

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

170

1078

1.59

7.44

1.9

2.2

10.14

10.44

mg/l

0.21

163

1030

(3013139) Helicobacter pylori Ag [Presence] in Stool

413

3103

1.35

7.42

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1343

11600

1.20

7.41

1.7

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

202

1333

1.53

7.41

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

508

6402

0.77

7.29

1.4

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

206

3001

0.67

7.29

1.2

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

257

1789

1.45

7.25

3.5

3.1

3.48

3.55

g/l

0.32

244

1706

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

165

1047

1.58

7.21

2.8

2.4

480.65

347.20

ug/l

0.29

148

945

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

378

4941

0.74

7.07

1.4

1.5

1.26

1.19

ratio

0.52

216

3017

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

378

4941

0.74

7.07

1.4

1.5

0.94

0.95

ratio

0.18

215

2991

(46235355) HIV 1 and 2 tests - Meaningful Use set

2509

22896

1.16

7.03

2.7

2.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

377

4925

0.74

7.02

1.4

1.5

1.22

1.16

ratio

0.64

214

2974

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

797

6568

1.24

7.00

3.2

2.5

0.94

1.06

e6/l

0.43

410

3104

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

206

1386

1.50

6.92

1.7

1.6

357.73

384.43

mu/l

0.50

177

1146

(3005033) Fetal Nuchal fold Thickness US

288

3909

0.72

6.87

1.4

1.5

1.24

1.26

0.34

213

2946

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

179

1173

1.53

6.81

1.4

10.36

14.40

u/l

2.12

157

1006

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

244

1703

1.44

6.80

3.0

3.1

167.34

167.50

0.01

229

1629

(3052851) Hemolysis interference index of Serum or Plasma

152

965

1.58

6.66

2.4

2.8

1.60

2.58

index

1.20

543

(3047352) Trisomy 18 risk [Likelihood] in Fetus

300

4024

0.73

6.65

1.4

1.5

—

(4062490) Immunoglobulin typing, IgG

511

1.80

6.63

1.3

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

156

998

1.57

6.61

1.7

—

(3036489) Thrombin time

274

1967

1.41

6.55

2.6

20.82

20.43

0.83

228

1698

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

107

624

1.72

6.53

1.1

—

1.56

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

6.13

6.42

5.1

10.5

215.71

87.71

e6/l

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

531

1.77

6.42

1.5

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

137

857

1.60

6.40

1.5

1.7

0.64

0.73

g/l

0.62

110

679

(3024666) Lithium [Moles/volume] in Serum or Plasma

539

1.77

6.39

12.9

12.6

0.60

0.58

mmol/l

0.29

494

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

427

3297

1.31

6.38

2.5

2.3

19.32

17.68

au/ml

0.29

463

(44816559) Phosphatidylethanol [Mass/volume] in Blood

394

3020

1.32

6.21

1.8

1.7

0.23

0.25

mg/l

0.48

156

1318

(4268621) Lupus anticoagulant assay

116

703

1.65

6.16

2.6

2.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

277

2.06

6.12

1.1

1.2

104.26

113.38

0.88

254

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

501

3974

1.28

6.10

1.4

1.3

222.45

233.48

miu/ml

0.30

251

1992

(3008898) HLA-B27 [Presence]

359

2723

1.33

6.09

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

280

2045

1.38

6.07

1.4

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

272

2.06

6.03

1.1

93.46

95.66

0.31

122

(3043238) Trisomy 21 risk [Likelihood] in Fetus

311

4085

0.74

6.02

1.4

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

454

1.81

6.01

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

557

1.73

6.00

2.0

1.6

0.00

g/l

-0.00

501

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

266

2.07

5.99

1.1

1.2

94.69

94.76

0.01

122

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

247

1770

1.41

5.99

2.8

3.1

98.55

95.49

1.50

238

1713

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

201

2.24

5.98

1.9

2.1

94.60

132.63

au/ml

—

(44813793) Dust mix specific IgE antibody measurement

528

1.75

5.98

1.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

443

3472

1.29

5.93

3.5

3.6

4.68

4.72

pmol/l

0.36

405

3183

(3007566) Smooth muscle Ab [Titer] in Serum

196

1349

1.46

5.93

1.3

1.4

75.43

91.24

titre

0.57

153

(3008152) Bicarbonate [Moles/volume] in Arterial blood

204

1416

1.45

5.91

6.6

7.1

23.91

23.81

mmol/l

0.14

198

1347

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.93

5.77

3.4

3.3

51.78

15.31

mg/l

0.62

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

233

1665

1.41

5.76

1.3

1.2

5.30

4.79

0.18

273

(3011288) Drugs identified in Urine by Screen method Nominal

611

5001

1.24

5.69

2.6

2.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

492

3928

1.27

5.69

3.5

2.5

32.78

47.59

u/l

0.64

428

3337

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.71

5.57

10.2

5.4

5.81

6.04

mmol/l

0.10

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

398

3106

1.30

5.52

1.3

1.2

35.83

39.01

au/ml

—

168

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

535

1.70

5.46

1.4

1.3

62.43

80.72

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

106

652

1.63

5.37

2.7

2.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

143

944

1.52

5.35

1.5

1.3

5.55

3.89

u/ml

0.53

459

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

338

4312

0.77

5.32

1.7

1.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

149

994

1.50

5.30

1.5

1.3

5.38

3.63

u/ml

0.23

406

(3035947) Staphylolysin Ab [Units/volume] in Serum

180

2.22

5.26

1.1

3.67

4.21

iu/ml

—

(3019225) pH of Specimen

346

2668

1.31

5.26

5.0

3.2

7.36

7.35

0.47

262

1944

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

209

1492

1.41

5.23

3.3

2.8

107.99

105.14

ng/l

0.05

179

1272

(3016879) Cocaine [Presence] in Urine

764

6454

1.21

5.22

2.0

2.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

213

1529

1.40

5.17

2.2

1.6

12.03

11.38

iu/ml

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

214

1538

1.40

5.16

13.2

11.8

23.68

23.99

mmol/l

0.78

208

1506

(3016650) Hepatitis A virus Ab [Presence] in Serum

151

1020

1.49

5.08

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

272

1.95

4.97

1.8

1.6

1.60

2.48

nmol/l

0.51

203

(3004716) Salmonella sp identified in Stool by Organism specific culture

505

4110

1.24

4.97

1.3

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

142

952

1.50

4.96

1.3

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

106

666

1.59

4.96

2.8

29.46

31.84

umol/l

0.77

623

(3024932) HLA-DR beta [Type]

153

2.28

4.95

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

476

1.70

4.91

1.6

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

207

1493

1.39

4.90

13.3

11.6

16.14

16.38

0.52

201

1436

(3024471) HLA-A [Type]

154

2.27

4.88

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

298

3816

0.76

4.84

1.4

1.6

63.49

59.44

ug/l

0.77

298

3816

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

156

1072

1.46

4.83

1.1

2.64

2.67

eliau/ml

0.02

535

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

368

4584

0.78

4.81

1.5

1.7

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

4557

43969

1.17

4.73

18.5

12.9

333.87

334.06

g/l

0.76

4523

43664

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

284

1.90

4.73

1.3

1.2

—

(4195642) Thrombophilia screening test

131

874

1.50

4.71

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

416

1.73

4.66

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

431

1.72

4.66

1.5

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

307

1.86

4.65

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

232

1723

1.35

4.61

1.7

1.5

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

3.09

4.58

1.6

2.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

241

1802

1.34

4.58

1.6

0.38

0.44

nmol/l

0.52

203

1492

(3014007) Fractional oxyhemoglobin in Arterial blood

224

1658

1.36

4.55

13.4

11.8

94.18

94.46

0.21

224

1648

(3014051) Protein [Presence] in Urine by Test strip

1625

14716

1.14

4.52

2.8

2.5

0.08

0.07

0.01

149

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

104

668

1.56

4.47

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

104

668

1.56

4.47

1.3

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

314

2450

1.29

4.42

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

130

879

1.48

4.40

1.7

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

129

871

1.48

4.40

1.1

113.19

115.17

0.34

116

790

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

733

6273

1.19

4.33

3.4

2.6

2.83

4.16

e6/l

2.86

344

2785

(3028300) Cannabinoids [Presence] in Urine

808

6974

1.18

4.31

2.0

2.1

—

(3028707) Methadone [Presence] in Urine by Screen method

364

2903

1.26

4.30

2.7

2.8

—

(3019060) Gas panel - Arterial blood

177

1275

1.39

4.27

4.9

5.4

—

(3027008) Opiates [Presence] in Urine

805

6952

1.18

4.27

2.0

2.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.48

4.26

5.0

4.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

184

2.06

4.23

11.0

4.6

4469.60

72.96

mg/l

0.49

140

(3027944) Amphetamines [Presence] in Urine

796

6873

1.18

4.23

2.0

2.1

—

(3037121) Protein [Mass/volume] in Urine

187

1363

1.38

4.21

4.4

3.8

435.51

354.69

mg/l

0.34

115

709

(3012501) Base excess in Blood by calculation

110

728

1.51

4.15

7.3

3.3

2.02

1.91

mmol/l

0.19

401

(3000764) Benzodiazepines [Presence] in Urine

798

6920

1.17

4.02

2.0

2.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

171

1239

1.38

4.01

1.2

1.1

28.82

16.00

au/ml

0.38

350

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

301

1.79

4.00

3.1

3.8

216.45

180.19

umol/l

0.34

173

(4035726) Immunohistochemistry procedure

296

2324

1.28

4.00

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

256

1975

1.30

3.96

1.6

1.5

—

(40761536) Microorganisms panel - Urine sediment

511

4268

1.21

3.95

4.6

3.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

317

1.76

3.95

3.4

3.1

—

(3042631) Mycobacterium sp identified in Specimen

224

1.92

3.93

1.9

3.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

105

2.37

3.92

1.4

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

618

1.54

3.91

1.6

1.7

15783.18

12606.53

e6/l

0.25

459

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

170

2.05

3.89

1.2

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

462

1.62

3.89

1.8

2.8

97.30

97.57

0.02

435

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

135

945

1.43

3.87

1.8

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

366

1.69

3.79

1.3

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

134

941

1.43

3.78

5.1

5.8

0.95

0.92

0.38

126

881

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

497

1.59

3.77

15.9

18.2

17666.96

802.32

nmol/l

0.49

483

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

130

909

1.43

3.76

2.6

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

102

680

1.50

3.76

1.3

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

242

1.86

3.76

1.3

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

128

893

1.44

3.75

1.2

1.1

2.85

2.54

0.13

173

(3049717) Cytology report of Urine Cyto stain

553

1.56

3.74

2.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

398

1.66

3.73

1.5

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

661

1.50

3.63

1.7

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

558

1.54

3.61

1.8

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

558

1.54

3.61

1.8

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

590

1.53

3.60

1.9

1.8

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

387

1.65

3.59

1.1

1.0

17.36

13.83

u/ml

0.43

253

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

312

1.73

3.58

1.1

—

(44806118) Parainfluenza type 4 nucleic acid detection

559

1.54

3.58

1.8

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

559

1.54

3.58

1.8

1.6

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

631

1.51

3.58

1.2

1.1

95.09

95.46

0.04

594

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

137

977

1.40

3.57

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

473

1.58

3.56

1.9

1.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

320

1.72

3.56

1.8

1.5

1.14

1.37

nmol/l

1.07

298

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

197

1.92

3.56

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

143

2.09

3.53

1.0

0.18

u/ml

0.01

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

121

846

1.43

3.52

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

212

1.88

3.51

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

428

1.61

3.51

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

118

2.20

3.45

2.2

2.3

84.41

86.63

ng/l

0.07

118

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

133

950

1.40

3.45

1.2

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

472

1.57

3.37

3.0

2.7

64.05

47.53

mg/l

0.56

402

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

433

1.59

3.37

1.1

1811.56

1408.64

miu/ml

1.83

433

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

296

1.72

3.35

1.4

1.2

74.39

71.78

u/l

0.10

263

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

473

1.56

3.34

3.0

2.7

46.00

31.95

mg/l

1.14

402

(3010144) Erythrocytes [#/volume] in Synovial fluid

216

1.85

3.33

1.5

1.4

79990.90

49258.58

e6/l

0.21

142

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

419

1.60

3.32

2.8

2.5

3.99

1.67

ratio

0.66

224

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

225

1.82

3.26

1.6

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

337

1.66

3.24

1.6

1.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

295

2380

1.25

3.23

1.2

1.1

2.16

2.99

u/ml

0.90

187

1317

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1184

10709

1.13

3.23

2.5

2.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.66

3.18

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

191

1.88

3.18

1.9

1.7

3.36

3.06

mg/l

0.12

184

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

264

1.74

3.16

2.3

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

441

1.56

3.14

1.1

1.3

0.18

0.20

nmol/l

0.24

324

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.30

3.12

2.8

3.4

10.36

12.04

kpa

1.42

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.30

3.12

2.8

3.4

4.98

4.71

kpa

0.84

(3038026) Centromere Ab [Units/volume] in Serum

236

1.78

3.11

1.4

1.2

40.22

33.83

u/ml

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

2.61

3.09

1.8

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

427

1.57

3.09

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

103

719

1.43

3.07

5.2

6.0

377.48

374.79

umol/l

0.07

638

(3014148) Varicella zoster virus Ab [Titer] in Serum

170

1288

1.32

3.07

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

238

1.76

3.03

1.2

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

1545

14232

1.11

3.02

2.6

2.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.88

2.99

1.0

1.1

54.58

44.08

mg/l

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

167

1.91

2.99

1.3

1.2

60.24

86.17

u/l

1.61

145

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

106

2.16

2.98

1.0

0.01

u/ml

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

496

1.51

2.95

1.2

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

464

1.53

2.95

1.2

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

610

5310

1.16

2.95

3.7

1.66

ug/l

0.00

562

4874

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

140

1039

1.35

2.93

2.7

2.6

35.49

25.02

iu/ml

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.42

2.87

1.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

483

1.51

2.87

1.2

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

467

1.52

2.87

1.2

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.36

2.85

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

468

1.52

2.85

1.2

1.4

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

207

1.78

2.81

2.3

2.5

179.81

64.82

nmol/l

1.03

202

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

227

1810

1.26

2.80

1.7

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

102

726

1.40

2.77

1.6

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

115

836

1.38

2.76

2.7

2.1

133.72

133.83

g/l

0.02

100

706

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

238

1.72

2.75

2.0

1.5

4.99

6.14

u/l

1.00

201

(3010726) Horse dander IgE Ab [Units/volume] in Serum

256

2074

1.24

2.75

1.1

2.83

2.94

u/ml

0.05

165

1155

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

268

2182

1.23

2.75

1.7

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

139

1044

1.33

2.71

4.9

5.4

1.61

1.69

0.34

132

980

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

118

2.03

2.67

1.4

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

348

1.58

2.66

1.3

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

132

1.96

2.65

2.8

0.81

0.90

nmol/l

0.39

100

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

197

0.35

2.65

1.0

1.1

1.20

1.17

mom

—

197

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

279

1.64

2.64

1.5

1.3

—

39.64

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

168

1.84

2.62

1.2

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

168

1.84

2.62

1.2

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

168

1.84

2.62

1.2

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

133

1.95

2.60

1.8

1.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.20

2.60

3.4

6.0

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

3.32

2.58

1.8

3.90

9.05

pmol/l

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

162

1.85

2.57

1.3

1.2

12.67

22.39

u/l

1.00

139

(3037756) Immunofixation for Serum or Plasma

297

1.61

2.56

1.4

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

554

1.44

2.55

1.9

2.1

4.79

5.14

mmol/24h

0.54

515

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.98

2.55

1.1

1.2

—

(3022725) Serotonin [Moles/volume] in Serum

3.98

2.55

1.3

1.5

464.63

1532.35

nmol/l

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

275

1.63

2.52

1.0

1.1

93.75

90.51

0.22

220

(3001556) Androgen free Index in Serum or Plasma

150

1.86

2.47

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

179

1.78

2.46

1.7

1653.33

2068.15

titre

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

187

1.76

2.44

1.0

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

210

1.71

2.41

1.5

1.3

83.85

89.42

nmol/24h

0.25

210

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

2.08

2.39

3.5

5.8

26.80

23.95

mg/l

0.44

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

4.98

2.39

19.8

4.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

226

1.68

2.38

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

257

1.63

2.36

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

257

1.63

2.36

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

257

1.63

2.36

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

124

1.93

2.36

1.2

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

440

1.47

2.36

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

246

2022

1.22

2.35

1.1

0.87

1.43

u/ml

1.32

135

1001

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

473

1.46

2.35

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.62

2.35

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

227

1.67

2.34

1.1

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

4.10

2.34

1.4

1.0

31.86

27.05

mg/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2283

21619

1.08

2.34

3.0

2.7

—

estimate

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

256

2114

1.21

2.34

1.1

7.99

7.63

u/ml

0.10

153

1271

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

549

1.42

2.31

1.3

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

483

1.45

2.31

1.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

161

1.80

2.30

1.1

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

168

1327

1.27

2.30

1.5

429.89

443.43

mg/l

0.16

161

1266

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

259

1.62

2.30

3.4

2.3

—

(3022313) Gas panel - Capillary blood

199

1604

1.24

2.29

4.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

427

1.47

2.28

2.8

4.6

6.78

6.80

mmol/l

0.01

345

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

252

1.62

2.28

1.3

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.17

2.27

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

112

1.96

2.26

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

119

1.93

2.26

1.2

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

426

3689

1.16

2.26

3.3

3.1

32.77

31.79

1.11

323

2813

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

511

1.43

2.24

1.4

1.5

388.75

614.82

pmol/l

0.57

445

(3024891) Influenza virus A+B Ag [Presence] in Specimen

218

1780

1.23

2.24

1.2

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

178

1.74

2.21

1.3

1.2

88.82

88.58

0.01

(3045424) Erythrocytes [Presence] in Urine

249

2068

1.21

2.17

2.1

1.9

0.00

0.33

estimate

0.57

834

(4034850) Laboratory test

135

1047

1.29

2.16

11.5

6.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

616

6814

0.89

2.13

1.9

2.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.77

2.12

9.3

5.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.15

2.11

1.2

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

159

1.75

2.09

1.1

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

107

808

1.32

2.09

11.2

2.7

0.86

0.84

nmol/l

0.07

712

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

174

1.72

2.09

2.2

1.9

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.44

2.07

1.7

1.3

12.93

5.42

pmol/l

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

123

1.86

2.07

1.2

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

214

1760

1.22

2.07

1.1

6.60

4.54

u/ml

0.35

128

981

(3008295) Osmolality of Serum or Plasma

404

1.46

2.06

1.9

2.0

289.23

287.70

mosm/kgh2o

0.19

311

(3050794) Legionella sp Ab [Presence] in Serum

2.89

2.05

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.12

2.05

1.2

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

149

1180

1.26

2.04

1.4

3.57

3.56

mmol/l

0.00

144

1117

(1761482) Bacteria [#/volume] in Urine by Culture

538

1.39

2.04

2.9

2.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

124

1.85

2.03

1.2

1.1

—

(40768793) Breast Pathology biopsy report

114

873

1.30

2.03

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

455

1.43

2.03

1.6

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

151

1199

1.26

2.02

1.5

1.6

1567.40

4072.27

e6/l

0.34

124

922

(3051611) Lipemic interference index of Serum or Plasma

301

1.52

2.00

2.3

3.8

14.03

15.07

index

0.34

228

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.39

2.00

1.1

0.02

u/ml

1.17

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

207

1.64

1.99

4.5

4.9

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

490

1.41

1.99

1.2

—

(3003181) Sodium [Moles/volume] in Urine

399

1.45

1.99

1.6

2.1

71.94

72.32

mmol/l

0.02

340

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

149

1187

1.26

1.95

1.4

1.5

18.45

21.56

e6/l

0.14

115

864

(3012494) Peanut IgE Ab [Units/volume] in Serum

311

1.51

1.95

1.1

5.93

33.46

u/ml

0.52

206

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

252

2119

1.19

1.95

2.2

2.3

40.11

31.96

u/ml

0.22

244

2041

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

178

1.68

1.94

1.2

67.00

75.00

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

159

1277

1.25

1.94

2.0

2.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

463

4083

1.14

1.93

3.2

21.28

21.17

0.03

140

1296

(3023419) Bacteria identified in Sputum by Culture

280

1.53

1.92

4.5

4.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.97

1.92

1.2

1.4

—

(1002224) Polysomnography panel

287

2446

1.18

1.90

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.91

1.87

1.1

1.4

—

(3013727) Leukocytes other/Leukocytes in Blood

1.95

1.87

4.3

3.7

55.18

47.30

0.78

(3008536) Aspergillus sp Ab [Presence] in Serum

2.14

1.85

1.0

3.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

356

1.46

1.85

1.1

124.37

118.15

pmol/l

0.49

356

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

481

1.39

1.84

1.7

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

107

1.86

1.83

4.1

3.4

1.10

1.16

0.09

107

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.38

1.83

6.0

4.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

653

1.33

1.81

1.6

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

424

1.41

1.81

1.2

1.1

1.10

1.05

ratio

0.87

363

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

441

1.40

1.80

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.05

1.78

2.3

1.7

—

(3017704) Immunofixation for Urine

1.99

1.77

1.1

1.6

—

(3045414) Leukocytes [Presence] in Urine

439

3885

1.13

1.76

2.2

1.9

0.02

0.04

estimate

0.85

125

994

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

473

1.37

1.68

1.3

1200.00

986.75

titre

0.94

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

172

1419

1.21

1.67

4.2

24.12

24.38

mmol/l

0.79

165

1372

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

194

1622

1.20

1.65

2.0

2.2

2.31

3.47

iu/l

4.57

746

(3024263) Appearance of Synovial fluid

126

1.74

1.64

1.9

2.1

—

(4198724) Urine methamphetamine measurement

673

1.31

1.64

2.8

3.0

—

(3036180) Methadone [Presence] in Urine

2.79

1.64

4.9

2.4

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

227

1.54

1.63

1.6

1.5

39.71

40.08

0.02

144

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

172

1.62

1.63

2.0

1.5

8.05

5.14

u/l

0.58

133

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.85

1.63

1.3

1.1

2.03

14.24

u/ml

—

(3014271) Vancomycin [Susceptibility]

2.09

1.63

2.5

2.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

553

1.34

1.62

1.5

1.6

—

titre

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.13

1.59

1.1

1.3

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.99

1.57

1.2

1.0

193.17

272.35

u/ml

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.81

1.54

1.6

1.4

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

247

1.49

1.53

1.2

1.1

—

(40763791) Oxygen content in Venous blood by calculation

3.32

1.51

13.0

4.0

12.96

14.27

ml/dl

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

449

1.35

1.50

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

138

1.66

1.48

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.15

1.48

1.4

1.2

38.22

38.70

g/l

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

146

1.64

1.47

1.1

1.0

23.88

3.70

u/ml

0.41

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

494

1.33

1.46

2.0

1.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

101

1.77

1.46

1.6

1.4

10.78

8.76

ug/l

1.03

101

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

426

1.36

1.45

1.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

147

1.63

1.44

1.1

1.0

0.30

0.68

u/ml

0.36

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

191

1618

1.18

1.43

2.2

1.9

—

(3019230) Fractional oxyhemoglobin in Venous blood

776

1.26

1.43

6.0

4.1

64.82

63.43

0.31

769

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

1.83

1.43

2.6

3.6

3.36

3.48

mg/l

0.08

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.71

1.42

4.2

3.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.87

1.42

1.1

2.0

112.37

31.00

ng/l

—

(3020876) Protein [Mass/time] in 24 hour Urine

293

1.43

1.42

2.9

2.8

1.98

1.54

g/24h

0.49

191

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

437

1.35

1.41

1.2

1.1

—

(3010503) CD19 cells [#/volume] in Blood

236

1.48

1.40

2.6

3.0

139.74

160.93

e6/l

0.29

230

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

172

1.56

1.39

1.1

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.81

1.39

1.1

1.0

—

(4015189) Microbial culture of sputum

2.40

1.38

1.9

3.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

439

1.34

1.37

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

561

1.30

1.36

1.2

1.1

13.82

14.64

u/ml

0.10

247

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

200

1710

1.17

1.36

4.4

4.3

5.22

38.50

ug/l

0.87

155

1203

(3047181) Lactate [Moles/volume] in Blood

110

890

1.23

1.35

5.3

5.6

1.21

1.20

mmol/l

0.04

782

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

119

1.67

1.35

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.79

1.34

2.2

2.7

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

485

1.32

1.33

1.4

1.2

0.62

0.68

ratio

0.50

275

(40759836) Histone Ab [Presence] in Serum by Immunoblot

442

1.33

1.32

1.2

1.1

—

(3022689) Creatine [Moles/volume] in Urine

1.75

1.32

1.9

1.6

9.15

10.16

mmol/l

0.33

(4024509) Urine culture

213

1838

1.16

1.30

2.1

1.7

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

257

1.43

1.30

1.1

12.41

8.20

u/ml

0.19

178

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.49

1.29

1.5

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.34

1.28

1.4

—

(21494755) Public health laboratory ask at order entry panel

675

7224

0.92

1.28

1.2

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

292

1.40

1.26

1.3

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

343

1.37

1.26

1.5

2.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

153

1.56

1.25

1.7

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.04

1.25

2.9

1.6

13.22

25.74

nmol/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.04

1.25

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

186

1.50

1.23

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

190

1635

1.16

1.22

1.2

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

123

1.62

1.21

1.2

1.3

133.97

103.06

nmol/l

0.51

(3022806) Fractional oxyhemoglobin in Capillary blood

423

1.32

1.21

2.1

1.9

92.11

91.80

0.23

417

(3032641) Amino acids panel - Urine

2.62

1.21

1.0

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1858

19171

0.95

1.20

1.7

1.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

502

1.29

1.20

1.3

1.2

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.03

1.20

1.1

—

(44806420) Estimation of glomerular filtration rate

529

1.28

1.19

2.0

1.8

—

(3018333) Ribosomal P Ab [Presence] in Serum

416

1.32

1.18

1.2

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

188

1.48

1.18

1.3

1.5

13.60

14.00

pmol/l

0.18

159

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

124

1.61

1.18

1.1

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

124

1.61

1.18

1.1

1.4

—

(3034426) Prothrombin time (PT)

180

1.49

1.18

1.4

1.2

28.52

28.32

0.06

180

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

132

1.58

1.17

1.2

1.0

0.20

0.74

u/ml

0.84

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.74

1.16

1.0

—

(3025130) Human papilloma virus identified in Specimen

149

1263

1.18

1.16

2.1

1.9

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

426

1.31

1.16

1.2

1.1

—

(3022670) pH of Venous cord blood

0.00

1.15

0.0

1.1

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

1.15

0.0

1.2

—

-1.32

—

(3006598) pH of Arterial cord blood

0.00

1.15

0.0

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.49

1.14

1.0

1.1

7.20

12.60

u/l

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

435

0.71

1.13

1.3

61.03

66.71

ug/l

0.44

435

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

248

1.41

1.13

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

472

1.29

1.13

2.0

0.82

2.92

u/ml

3.28

161

(3039000) Anion gap in Blood by calculation

516

1.28

1.13

6.9

8.0

12.10

11.62

mmol/l

0.52

465

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

350

3153

1.11

1.12

2.6

2.5

0.58

0.65

ug/l

1.37

179

1492

(3024869) Neuronal Ab [Presence] in Serum

2.32

1.12

1.1

1.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

126

1.58

1.12

1.1

1.0

3.03

1.21

u/ml

0.26

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

126

1.58

1.12

1.6

1.7

85.80

124.78

ug/min

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

274

1.38

1.12

1.3

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

232

1.42

1.12

1.5

1.2

0.28

g/l

0.26

190

(3018572) Chloride [Moles/volume] in Blood

517

1.27

1.11

6.9

8.0

106.13

105.62

mmol/l

0.41

466

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.74

1.11

1.1

1.2

—

(40757373) Influenza virus identified in Isolate

1.89

1.10

2.9

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.77

1.09

2.8

5.7

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

189

1643

1.15

1.08

1.1

4.65

7.61

u/ml

1.83

832

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

423

1.30

1.07

2.1

3.0

189.64

207.54

e6/l

0.28

336

(3002523) Influenza virus A Ag [Presence] in Specimen

188

1636

1.15

1.07

1.2

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

168

1.48

1.07

1.2

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

168

1.48

1.07

1.2

1.9

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.11

1.05

2.9

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

461

1.28

1.03

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

578

1.24

1.01

1.2

1.1

259.84

208.99

mg/l

0.58

504

(3038177) Helicobacter pylori Ab [Presence] in Serum

120

1014

1.18

1.01

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

660

1.22

1.00

1.8

2.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.99

0.99

1.6

1.5

344.51

596.21

nmol/l

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

394

1.29

0.98

1.0

1.1

—

0.53

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

545

1.24

0.98

1.3

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.97

0.0

1.1

—

32.41

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

599

1.23

0.97

1.4

1.1

54.57

36.47

mg/l

0.85

500

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

265

1.35

0.96

1.1

7.86

16.84

u/ml

—

(3006462) Nitrate [Presence] in Urine

210

0.61

0.96

3.4

2.1

—

(3006653) Thiamine [Moles/volume] in Blood

189

1.42

0.96

1.4

150.45

133.58

nmol/l

1.15

189

(3045683) HLA typing for celiac disease panel - Blood or Tissue

475

1.26

0.96

1.0

—

(3033099) Centromere Ab [Titer] in Serum

1.66

0.96

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

1.62

0.95

1.1

1.5

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.95

0.0

1.2

—

69.02

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

116

0.51

0.94

1.0

1.1

1.07

6.32

u/ml

—

116

(4211845) Urine protein measurement

232

0.64

0.93

3.8

2.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

335

3049

1.10

0.92

1.5

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

167

1461

1.14

0.91

1.1

0.17

0.38

u/ml

1.36

448

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

144

1247

1.15

0.91

2.2

1.9

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.13

0.91

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

498

1.24

0.89

3.7

4.6

44.23

109.12

u/ml

1.17

172

(3020191) Ethanol [Moles/volume] in Serum or Plasma

552

1.23

0.89

1.3

1.6

1.25

1.30

promille

0.12

429

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

158

1381

1.14

0.88

2.3

1.9

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

102

1.56

0.88

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.85

0.87

1.1

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.99

0.86

2.0

1.2

1.13

1.80

mg/l

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.81

0.85

1.1

—

(3025577) Chromium [Mass/volume] in Blood

1.81

0.85

2.4

2.3

4.65

2.64

ug/l

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.81

0.85

1.1

1.2

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

353

0.73

0.84

5.7

6.4

10.15

8.74

0.39

353

(40761995) Spermatozoa Progressive [#/volume] in Semen

353

0.73

0.84

2.8

3.2

40.50

44.82

0.46

353

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

254

2775

0.91

0.82

1.0

1.1

0.67

0.62

ratio

0.33

211

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.56

0.82

1.0

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

1.56

0.82

1.0

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.56

0.82

1.0

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.56

0.82

1.0

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

335

1.28

0.81

1.4

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

130

1130

1.15

0.81

1.6

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

146

1.43

0.80

1.0

1.1

0.15

1.44

u/ml

1.22

113

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1878

18155

1.04

0.80

2.0

1.9

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.64

0.80

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

771

1.18

0.79

2.9

2.0

12.60

465.49

pmol/l

2.24

110

(3044242) Glucose [Moles/volume] in Arterial blood

122

1.47

0.78

1.8

2.1

7.35

7.65

mmol/l

0.11

122

(3045716) Anion gap in Serum or Plasma by calculation

276

1.30

0.77

2.7

2.3

10.75

10.53

mmol/l

0.14

268

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.61

0.76

1.0

1.2

—

307.27

—

(40765096) Chromosome analysis panel by Banding

1.58

0.76

1.3

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

410

1.24

0.76

2.1

2.9

688.66

526.96

e6/l

0.95

315

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.16

0.76

1.0

0.08

0.03

u/ml

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1748

16896

1.04

0.75

2.1

1.9

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.07

0.74

1.0

1.35

5.79

u/ml

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

226

2466

0.91

0.74

1.3

3.34

3.90

ug/l

1.30

216

2357

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

119

1037

1.14

0.73

1.7

2.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.63

0.73

1.7

1.4

—

(3042517) Benzodiazepines panel - Urine

166

1.38

0.73

2.5

2.7

—

(3011412) CD3 cells [#/volume] in Blood

503

1.21

0.73

2.4

2.8

1434.29

1327.58

e6/l

0.35

414

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

175

1.37

0.72

1.1

27.49

196.56

ng/l

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.99

0.72

1.0

1.2

0.01

2.44

u/ml

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

100

1.49

0.71

1.0

1.1

0.02

0.09

u/ml

1.38

100

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.74

0.71

2.6

2.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.66

0.70

2.7

1.9

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.91

0.70

7.2

5.9

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.61

0.70

4.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

397

1.23

0.70

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.70

0.69

3.3

1.5

—

(3044927) Protein electrophoresis panel - Urine

134

1.41

0.69

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

398

1.23

0.68

1.2

1.1

0.93

1.00

u/l

1.23

154

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

273

1.28

0.68

3.1

2.9

55.09

51.34

umol/l

0.39

252

(3045142) Bone marrow Pathology biopsy report

273

1.28

0.68

1.2

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

256

2350

1.09

0.64

1.4

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

162

1.35

0.64

1.4

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

162

1.35

0.64

1.4

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

162

1.35

0.64

1.4

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

162

1.35

0.64

1.4

1.7

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

206

1.30

0.63

1.3

2.0

0.21

0.18

nmol/l

0.20

172

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

440

1.20

0.62

1.2

1.3

68.00

298.52

titre

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

495

1.19

0.61

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

172

1.33

0.61

1.8

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

496

1.18

0.60

2.8

3.2

—

(3047189) Immunofixation for 24 hour Urine

1.58

0.60

1.8

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

243

1.27

0.60

1.8

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

451

1.19

0.60

1.1

1.3

3.39

4.06

u/ml

0.14

239

(3002079) Sodium [Moles/time] in 24 hour Urine

235

1.27

0.59

1.4

1.5

130.13

163.22

mmol/24h

2.34

235

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.58

0.0

1.2

—

122.29

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

638

1.16

0.57

1.0

1.1

7.46

2.87

u/ml

0.72

196

(3005082) Progesterone [Moles/volume] in Serum or Plasma

971

0.88

0.56

1.5

32.77

37.18

nmol/l

0.67

900

(46235168) Fasting glucose [Moles/volume] in Blood

0.56

1.0

1.1

—

9.29

—

(40768441) Liver Pathology biopsy report

291

1.23

0.55

1.5

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

843

0.87

0.55

1.6

1.4

0.53

0.52

e9/l

0.14

843

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.57

0.54

1.5

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.57

0.54

1.0

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

512

1.17

0.54

1.1

7.48

6.70

iu/ml

0.12

144

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

108

961

1.12

0.53

1.2

113.10

1903.98

iu/ml

0.92

259

(4094501) Cardiovascular stress test using bicycle ergometer

661

1.15

0.53

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

186

1.28

0.52

1.8

1.6

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.60

0.51

1.7

1.4

5.03

5.38

mmol/l

—

(3017569) Oxygen content in Arterial blood

100

1.39

0.50

2.1

2.3

16.10

17.22

0.59

100

(21494434) Karyotype in Bone marrow

197

1.26

0.49

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

1.55

0.48

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

361

1.19

0.48

2.2

3.0

0.80

0.72

e9/l

0.50

354

(3000012) Reticulocyte production index

288

1.21

0.48

2.0

2.2

0.94

0.88

0.20

167

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

262

1.22

0.46

1.6

1.3

75.00

71.79

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

186

0.75

0.45

1.0

1.1

35.26

35.35

iu/ml

0.00

186

(21494814) CD8 cells/Lymphocytes in Specimen

155

1.28

0.45

2.8

2.3

26.85

28.85

0.33

155

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.37

0.43

1.1

86.86

81.57

titre

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.60

0.43

2.6

1.7

—

(3022621) pH of Urine by Test strip

359

3745

0.95

0.41

2.7

2.1

6.21

6.26

0.53

225

2310

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

275

1.19

0.41

1.6

1.9

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

312

1.18

0.41

1.7

1.6

52.55

48.16

0.29

210

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

268

2520

1.06

0.41

1.5

1.6

4.59

4.21

mg/l

0.28

187

1725

(3017950) Salicylates [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.9

—

1524.63

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.42

0.40

1.3

1.7

8.48

1.92

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.42

0.40

1.3

1.7

3.12

1.48

mg/l

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

131

1.29

0.40

1.3

1.5

38676.57

30597.80

e6/l

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

212

1.22

0.40

1.1

0.84

5.39

u/ml

0.87

191

(44806071) Cardiolipin IgM antibody measurement

1.35

0.40

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

187

1739

1.07

0.40

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

565

1.13

0.40

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.39

0.0

1.6

—

1.95

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

186

1.23

0.38

1.9

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

186

1.23

0.38

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

232

1.20

0.38

9.1

7.5

130.60

183.66

u/ml

—

(4281824) Cell count and differential, peritoneal fluid

278

0.82

0.37

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

653

1.11

0.37

1.0

1.1

8.37

2.24

u/ml

0.37

267

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

146

0.75

0.37

1.2

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1.30

0.37

1.1

1.0

21.56

28.06

ng/l

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1.30

0.37

1.1

1.0

993.00

822.50

ng/l

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

266

0.82

0.36

1.6

1.2

64.27

72.14

umol/l

2.31

266

(3000034) Microalbumin [Mass/volume] in Urine

215

1.20

0.36

4.6

3.1

164.63

57.32

mg/l

0.64

160

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.46

0.36

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1.26

0.36

1.1

1.0

203.89

226.16

ng/l

—

(3023410) Appearance of Cerebral spinal fluid

600

1.11

0.34

1.5

1.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

422

1.13

0.33

1.7

1.5

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

338

1.15

0.33

1.3

1.1

7.85

7.21

mm/h

0.21

338

(3000060) B lymphocytes [#/volume] in Blood

273

1.17

0.33

2.0

2.7

0.11

0.20

e9/l

1.07

138

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.33

0.33

1.0

2.1

—

13100.00

u/ml

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.33

0.33

1.2

1.3

2.34

1.79

iu/ml

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.31

0.32

1.2

1.1

—

(40758292) HTLV I+II Ab panel - Serum

127

1.25

0.32

1.0

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

122

1301

0.93

0.32

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

182

1.20

0.31

1.3

1.6

1.35

4.64

u/field

1.63

132

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.34

0.31

2.1

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

101

1.28

0.30

1.1

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.29

0.30

1.0

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

655

1.09

0.29

2.5

3.3

21.33

26.96

mu/l

1.11

606

(3051387) C reactive protein [Mass/volume] in Capillary blood

837

1.08

0.29

3.3

2.9

27.01

24.30

mg/l

0.36

551

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

120

1.24

0.29

1.3

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

102

1.27

0.29

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.22

0.28

2.0

1.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

215

0.83

0.28

1.1

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

401

1.12

0.27

2.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

121

1.23

0.27

1.0

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

112

1.24

0.27

1.6

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

112

1.24

0.27

1.6

1.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.31

0.27

1.3

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

279

1.14

0.27

1.7

2.0

—

(3016330) Potassium [Moles/time] in 24 hour Urine

1.21

0.26

1.9

1.4

—

99.48

—

(3012441) Differential panel - Pleural fluid

140

1.21

0.26

1.3

1.5

—

(3045788) Cell count panel - Pleural fluid

131

1.22

0.26

1.3

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.68

0.26

1.0

1.7

42.88

42.83

g/l

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.34

0.23

2.0

1.6

189.00

280.73

umol/24h

—

(3017509) Phencyclidine [Presence] in Urine

142

1.19

0.23

2.5

1.8

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.28

0.22

2.0

2.1

1.20

0.97

u/field

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

346

0.89

0.22

4.1

3.7

17.26

21.34

u/ml

0.51

337

(3023199) Leukocytes [#/volume] in Pleural fluid

152

1.18

0.22

1.3

1.4

1725.82

3598.05

e6/l

0.78

(3034274) Bile acid [Moles/volume] in Serum --fasting

228

2183

1.04

0.22

2.2

2.5

5.19

5.48

umol/l

0.13

170

1635

(3043410) Blood group antigens tested for on Red Blood Cells

134

1.19

0.21

3.1

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40760512) CD34 cells/cells in Bone marrow

0.00

0.21

0.0

1.8

—

(4038314) Semen analysis, post vasectomy

102

0.78

0.21

1.1

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

553

1.08

0.21

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.20

0.0

1.0

—

(4146454) Self-monitoring of blood glucose

206

0.87

0.19

2.5

2.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

720

1.06

0.19

5.2

4.1

193.42

2082.70

u/ml

0.77

629

(3027923) C peptide [Moles/volume] in Serum or Plasma

193

1.13

0.18

1.9

2.1

0.63

1.40

nmol/l

5.13

153

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

813

7960

1.02

0.18

1.6

3.43

3.44

ratio

0.06

579

5583

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

118

1.18

0.18

1.6

1.9

—

(3011897) Casein IgE Ab [Units/volume] in Serum

222

1.12

0.17

1.0

1.2

5.88

0.96

u/ml

0.40

222

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.14

0.17

23.7

6.1

8.29

5.38

kpa

—

(3035320) C reactive protein [Mass/volume] in Body fluid

380

0.92

0.17

3.5

2.2

20.86

27.53

mg/l

0.63

261

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

214

1.12

0.16

1.3

1.9

1.38

2.04

u/field

0.77

131

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

176

1.13

0.16

1.4

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

176

1.13

0.16

1.2

5.41

5.88

mmol/l

0.83

165

(40768806) Pleura Pathology biopsy report

129

1.16

0.16

1.5

1.6

—

(3007463) Buprenorphine [Presence] in Urine

1.11

0.16

5.5

4.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

343

3487

0.98

0.15

1.5

1.6

—

(3010937) Rubella virus Ab [Presence] in Serum

1.09

0.14

1.1

—

(3020491) Glucose [Moles/volume] in Blood

383

0.93

0.12

1.6

5.66

5.72

mmol/l

0.08

320

(3004451) EKG impression Narrative

105

1.14

0.10

1.3

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.16

0.10

1.0

1.6

—

(3044007) Cell count panel - Peritoneal fluid

1.06

0.09

1.8

2.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.06

0.09

1.0

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

0.83

0.08

1.6

1.8

120.98

216.64

mu/l

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.13

0.08

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.11

0.08

1.1

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

194

1.08

0.08

1.1

—

0.15

—

(3030313) Adrenal Ab [Titer] in Serum

107

1.12

0.07

1.1

1.2

—

35.83

—

(40768795) Lymph node Pathology biopsy report

312

1.05

0.07

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.03

0.07

1.3

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

225

1.06

0.06

7.1

8.2

1.99

75.13

ug/l

0.60

170

(3002619) Bacteria identified in Specimen by Culture

120

0.91

0.05

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

236

1.05

0.05

1.0

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

266

1.05

0.05

3.6

2.9

42.43

44.35

0.24

133

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

631

6244

1.01

0.04

1.5

1.4

3.24

3.36

mmol/l

1.93

411

3919

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

131

1.06

0.03

2.3

2.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

100

982

1.01

0.02

1.3

1.2

—

(3000330) Specific gravity of Urine by Test strip

163

1631

0.99

0.01

3.4

2.4

1.02

ratio

0.97

152

1409

(3020650) Glucose [Presence] in Urine

212

0.98

0.00

1.6

1.4

0.00

0.03

estimate

0.80

212

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

110

0.99

0.00

1.0

1.1

—

(4133840) Spirometry

147

1.01

0.00

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

155

1.03

0.00

3.1

2.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

181

0.99

0.00

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

604

1.00

0.00

1.1

1.0

0.93

1.08

u/ml

0.11

184

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

346

1.01

0.00

1.7

1.6

21.89

22.58

mg/l

—

131

(40768800) Prostate Pathology biopsy report

217

1.01

0.00

1.4

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.00

0.00

1.6

1.5

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.0

1.8

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

3.8

—

0.43

—

(3009992) Blasts/cells in Bone marrow

0.00

0.0

1.5

—

11.67

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.2

—

50.17

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

277.50

—

(3018487) Sunflower Seed IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1.43

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

1258.00

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.89

-0.00

1.9

1.1

1.19

1.18

mmol/l

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.2

—

165.00

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.8

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.86

-0.00

1.0

1.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

0.89

-0.00

1.5

4.6

—

4.00

—

(3019174) dRVVT (LA screen)

0.99

-0.00

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

0.86

-0.00

2.2

1.5

0.51

0.41

ug/l

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

-0.00

0.0

1.6

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.20

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

-0.00

0.0

3.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_ACNE and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_ACNE	2.128 [1.75, 2.59]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.347

During the follow-up period (1.1.1998 — 31.12.2019), 306 out of 13469 females with L12_ACNE died.

Males

Parameter	HR [95% CI]	p-value
L12_ACNE	1.88 [1.62, 2.18]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.055

During the follow-up period (1.1.1998 — 31.12.2019), 599 out of 16909 males with L12_ACNE died.

Mortality risk

Mortality risk for people of age

years, who have L12_ACNE.

N-year risk	Females	Males
1	0.146%	0.335%
5	1.172%	2.19%
10	3.024%	5.676%
15	6.046%	10.808%
20	10.594%	18.722%

Relationships between endpoints

↥

Index endpoint: L12_ACNE – Acne

GWS hits: 12

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Acne

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints